<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cerebellum Ataxias</journal-id>
<journal-id journal-id-type="iso-abbrev">Cerebellum Ataxias</journal-id>
<journal-title-group>
<journal-title>Cerebellum &amp; Ataxias</journal-title>
</journal-title-group>
<issn pub-type="epub">2053-8871</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26770813</article-id>
<article-id pub-id-type="pmc">4712469</article-id>
<article-id pub-id-type="publisher-id">39</article-id>
<article-id pub-id-type="doi">10.1186/s40673-016-0039-1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical and neuroimaging features as diagnostic guides in neonatal neurology diseases with cerebellar involvement</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Klein</surname>
<given-names>Jessica L.</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff2"></xref>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lemmon</surname>
<given-names>Monica E.</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff2"></xref>
<xref ref-type="aff" rid="Aff4"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Northington</surname>
<given-names>Frances J.</given-names>
</name>
<xref ref-type="aff" rid="Aff2"></xref>
<xref ref-type="aff" rid="Aff5"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boltshauser</surname>
<given-names>Eugen</given-names>
</name>
<xref ref-type="aff" rid="Aff6"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huisman</surname>
<given-names>Thierry A. G. M.</given-names>
</name>
<xref ref-type="aff" rid="Aff2"></xref>
<xref ref-type="aff" rid="Aff7"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Poretti</surname>
<given-names>Andrea</given-names>
</name>
<address>
<phone>+14109556454</phone>
<email>aporett1@jhmi.edu</email>
</address>
<xref ref-type="aff" rid="Aff2"></xref>
<xref ref-type="aff" rid="Aff6"></xref>
<xref ref-type="aff" rid="Aff7"></xref>
</contrib>
<aff id="Aff1"><label></label>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD USA </aff>
<aff id="Aff2"><label></label>Neurosciences Intensive Care Nursery Program, The Johns Hopkins University School of Medicine, Baltimore, MD USA </aff>
<aff id="Aff3"><label></label>Department of Pediatrics, Medical University of South Carolina, Charleston, SC USA </aff>
<aff id="Aff4"><label></label>Division of Pediatric Neurology, Department of Pediatrics, Duke University School of Medicine, Durham, NC USA </aff>
<aff id="Aff5"><label></label>Division of Neonatology, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD USA </aff>
<aff id="Aff6"><label></label>Division of Pediatric Neurology, University Children’s Hospital, Zurich, Switzerland </aff>
<aff id="Aff7"><label></label>Section of Pediatric Neuroradiology, Division of Pediatric Radiology, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Charlotte R. Bloomberg Children’s Center, Sheikh Zayed Tower, Room 4174, 1800 Orleans Street, Baltimore, MD USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>13</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>13</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>3</volume>
<elocation-id>1</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>12</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© Klein et al. 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>Cerebellar abnormalities are encountered in a high number of neurological diseases that present in the neonatal period. These disorders can be categorized broadly as inherited (e.g. malformations, inborn errors of metabolism) or acquired (e.g. hemorrhages, infections, stroke). In some disorders such as Dandy-Walker malformation or Joubert syndrome, the main abnormalities are located within the cerebellum and brainstem. In other disorders such as Krabbe disease or sulfite oxidase deficiency, the main abnormalities are found within the supratentorial brain, but the cerebellar involvement may be helpful for diagnostic purposes. In In this article, we review neurological disorders with onset in the neonatal period and cerebellar involvement with a focus on how characterization of cerebellar involvement can facilitate accurate diagnosis and improved accuracy of neuro-functional prognosis.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Cerebellum</kwd>
<kwd>Neonate</kwd>
<kwd>Neonatal neurology</kwd>
<kwd>Neuroimaging</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000071</institution-id>
<institution>National Institute of Child Health and Human Development</institution>
</institution-wrap>
</funding-source>
<award-id>NIH-HD070996</award-id>
<principal-award-recipient>
<name>
<surname>Northington</surname>
<given-names>Frances J.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p>In the last decade, remarkable progress has been made in neonatal neurology. The translation of this new information from the bench to the clinic has allowed for significant improvements in the diagnosis and treatment of neurological disorders of preterm and term neonates. At present, as many as 25 % of newborns in tertiary-level intensive care nurseries have primary neurological conditions and many more are at risk of neurologic injury [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
<p>The cerebellum accounts for only about 10 % of the brain volume, but contains approximately 50 billion neurons (more than 50 % of all the neurons of the brain) and 200 million input fibers. The cerebellum is highly connected with the cerebral hemispheres through numerous complex anatomical and functional cerebro-cerebellar circuits [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. The cerebro-cerebellar connections include the motor cortex and the supplementary motor area, the posterior and inferior parietal cortex, the superior temporal cortex, the prefrontal cortex, as well as the cingulate gyrus and the parahippocampal gyrus. The circuits of the cerebro-cerebellar connections are the likely structural basis for the important role of the cerebellum in motor and neurocognitive functions. In the last decades, understanding of cerebellar dysfunction has evolved from pure motor syndromes (impairments of gait, extremity coordination, speech, and ocular motor control) to more complex neurocognitive and neurobehavioral abnormalities that are collectively known as the “cerebellar cognitive affective syndrome” [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
<p>This review article focuses on disorders with cerebellar involvement that present during the neonatal period. Brainstem involvement has also been included because brainstem abnormalities often accompany cerebellar anomalies and cerebellar and brainstem embryological development is closely related. The diseases listed in this article have been selected from our clinical experience, consultation of textbooks on cerebellar disorders, neonatal neurology, neonatology, and neuroimaging, and a search of Pubmed with appropriate key words. The disorders have been broadly classified as inherited or acquired (Table <xref ref-type="table" rid="Tab1">1</xref>). Selected cerebellar and brainstem malformations such as rhombencephalosynapsis, the majority of cases of Dandy-Walker malformation, and pontine tegmental cap dysplasia have been classified as hereditary disorders although the genetic background is still unknown. Their origin is most likely hereditary (genetic), not acquired based on the neuroimaging findings and suggested patho-mechanisms.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Neonatal neurology diseases with clinical or neuroimaging cerebellar involvement</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Group of diseases</th><th>Diseases</th><th>Diagnostic test</th></tr></thead><tbody><tr><td rowspan="21">Inherited</td><td rowspan="8">Malformation</td><td>Dandy-Walker malformation</td><td>Brain MRI findings</td></tr><tr><td>Joubert syndrome</td><td>Brain MRI findings</td></tr><tr><td>Rhombencephalosynapsis</td><td>Brain MRI findings</td></tr><tr><td>Pontocerebellar hypoplasias</td><td>Brain MRI findings, genetic analysis</td></tr><tr><td>Congenital muscular dystrophy due to α-dystroglycanopathy</td><td>Muscle biopsy, genetic analysis</td></tr><tr><td>Brainstem disconnection</td><td>Brain MRI findings</td></tr><tr><td>Pontine tegmental cap dysplasia</td><td>Brain MRI findings</td></tr><tr><td>Chiari type II malformation</td><td>Brain MRI findings</td></tr><tr><td rowspan="6">Neurometabolic</td><td>Congenital disorders of glycosylation</td><td>Transferrin electrophoresis, genetic analysis</td></tr><tr><td>Smith-Lemli-Opitz syndrome</td><td>Elevated 7-dehydrocholesterol, genetic analysis</td></tr><tr><td>Non-ketotic hyperglycinemia</td><td>Elevated CSF glycine concentration and CSF-to-plasma glycine ratio, genetic analysis</td></tr><tr><td>Maple syrup urine disease</td><td>Elevated branched-chain amino acids and branched-chain keto-acids in blood and urine</td></tr><tr><td>Pyruvate dehydrogenase deficiency</td><td>Abnormal enzyme function, genetic analysis</td></tr><tr><td>Sulfite oxidase deficiency</td><td>Elevated sulfite, thiosulfate, taurine, and S-sulfocysteine concentrations in urine, genetic analysis</td></tr><tr><td rowspan="5">Neurodegenerative</td><td>Krabbe disease</td><td>Low galactocerebrosidase activity in peripheral leukocytes, genetic analysis</td></tr><tr><td>Cockayne syndrome</td><td>Genetic analysis</td></tr><tr><td>Pelizaeus-Merzbacher disease</td><td>Genetic analysis</td></tr><tr><td>Aicardi-Goutières syndrome</td><td>Genetic analysis</td></tr><tr><td>Congenital neuronal ceroid lipofuscinosis</td><td>Genetic analysis</td></tr><tr><td rowspan="2">Spinocerebellar ataxias</td><td>SCA type 2</td><td>Genetic analysis</td></tr><tr><td>SCA type 7</td><td>Genetic analysis</td></tr><tr><td rowspan="12">Acquired</td><td rowspan="3">Vascular</td><td>Cerebellar hemorrhage</td><td>Brain MRI findings</td></tr><tr><td>Sinovenous thrombosis</td><td>Brain MRI findings</td></tr><tr><td>cerebellar ischemic stroke</td><td>Brain MRI findings</td></tr><tr><td colspan="2">Disrupted development of the cerebellum in preterms</td><td>History of prematurity, brain MRI findings</td></tr><tr><td colspan="2">Hypoxic-ischemic injury</td><td>Brain MRI findings</td></tr><tr><td rowspan="2">Infection</td><td>Congenital cytomegalovirus</td><td>Viral culture, PCR, or serology within the first weeks of life, later PCR for CMV DNA in dried blood of neonatal screening</td></tr><tr><td>Herpes simplex</td><td>CSF viral culture or PCR</td></tr><tr><td>Toxic</td><td>Glucocorticoids</td><td>Brain MRI findings, history of glucocorticoids therapy</td></tr><tr><td rowspan="3">Teratogens</td><td>Alcohol</td><td>History, brain MRI findings</td></tr><tr><td>Retinoic acid</td><td>History, brain MRI findings</td></tr><tr><td>Misoprostol</td><td>History, brain MRI findings</td></tr><tr><td rowspan="2">Tumors</td><td>Teratoma</td><td>Histology</td></tr><tr><td></td><td>Medulloblastoma</td><td>Histology</td></tr></tbody></table><table-wrap-foot><p>
<italic>CMV</italic> cytomegalovirus, <italic>CSF</italic> cerebrospinal fluid, <italic>DNA</italic> deoxyribonucleic acid, <italic>MRI</italic> magnetic resonance imaging, <italic>PCR</italic> polymerase chain reaction</p></table-wrap-foot></table-wrap></p>
<p>The discussion of each disorder will emphasize how understanding of cerebellar involvement may facilitate diagnosis, elucidate pathogenesis, and affect long-term neurocognitive and behavioral outcomes of the affected preterm and term neonates. In addition, we provide checklists for selected clinical (Table <xref ref-type="table" rid="Tab2">2</xref>) and neuroimaging (Table <xref ref-type="table" rid="Tab3">3</xref>) findings. These checklists should facilitate making the correct diagnosis or narrow the differential diagnoses of neonatal neurological diseases with cerebellar involvement. These lists can be used as “memo-lists” and are not meant to be complete. Note that for a given condition a range of findings may occur and not all mentioned clinical and imaging findings have to be present.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Neonatal symptoms and clinical findings that may facilitate the diagnosis of neonatal disorders with cerebellar involvement</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Symptom/clinical finding</th><th>Diseases</th></tr></thead><tbody><tr><td>Alopecia</td><td>RES</td></tr><tr><td>Breathing abnormalities</td><td>BD, CII, cerebellar hemorrhage, CNCL, JS, NKH, PCH 1/4, PDH</td></tr><tr><td>Contractures</td><td>CMD, CS, PCH 4</td></tr><tr><td>Corneal insensitivity</td><td>PTCD, RES</td></tr><tr><td>Dysmorphic features</td><td>CDG, CS, JS, RES, SLO, SOD</td></tr><tr><td>Dysphagia</td><td>BD, CII, CMD, PCH 1/2/6, PTCD</td></tr><tr><td>Dystonia</td><td>MSUD, PCH 2</td></tr><tr><td>Eye involvement (cataract, coloboma, retinitis, …)</td><td>CMD, CMV, CNCL, CS, JS</td></tr><tr><td>Facial palsy</td><td>BD, PTCD</td></tr><tr><td>Head titubation</td><td>JS</td></tr><tr><td>Hyporeflexia</td><td>CDG, PCH 1</td></tr><tr><td>Irritability</td><td>Cerebellar hemorrhage, Krabbe, sinovenous thrombosis</td></tr><tr><td>Kidney involvement</td><td>JS, SLO</td></tr><tr><td>Macrocephaly</td><td>Cerebellar hemorrhage, CII, DWM, RES, sinovenous thrombosis, tumor</td></tr><tr><td>Microcephaly</td><td>CMV, CNCL, PCH (mainly type 6), PDH, SLO</td></tr><tr><td>Nystagmus</td><td>PMD</td></tr><tr><td>Ophthalmoplegia</td><td>MSUD</td></tr><tr><td>Polydactyly</td><td>JS</td></tr><tr><td>Ptosis</td><td>SLO</td></tr><tr><td>Seizures</td><td>BD, cerebellar hemorrhage and stroke, CMD, CMV, CNCL, HII, HSV, MSUD, NKH, preterm disruption, PCH 6, PDH, SOD</td></tr><tr><td>Skeletal abnormalities</td><td>BD, PTCD, SLO</td></tr><tr><td>Stridor</td><td>CII, PMD</td></tr><tr><td>Unstable body temperature</td><td>BD</td></tr><tr><td>Weakness</td><td>CMD, PCH 1</td></tr></tbody></table><table-wrap-foot><p>
<italic>BD</italic> brainstem disconnection, <italic>CDG</italic> congenital disorders of glycosylation, <italic> CII</italic> Chiari type II malformation, <italic>CMD</italic> congenital muscular dystrophy, <italic>CMV</italic> cytomegalovirus infection, <italic>CNCL</italic> congenital neuronal ceroid lipofuscinosis, <italic>CS</italic> Cockayne syndrome, <italic>DWM</italic> Dandy-Walker malformation, <italic>HII</italic> hypoxic-ischemic injury, <italic>HSV</italic> herpes simpex infection, <italic>JS</italic> Joubert syndrome, <italic>MSUD</italic> maple syrup urine disease, <italic>NKH</italic>, nonketotic hyperglycinemia, <italic>PCH</italic> pontocerebellar hypoplasia, <italic>PDH</italic> pyruvate dehydrogenase deficiency, <italic>PMD</italic> Pelizaeus-Merzbacher disease, <italic>PTCD</italic> pontine tegmental cap dysplasia, <italic>RES</italic> rhombencephalosynapsis, <italic>SLO</italic> Smith-Lemli-Opitz syndrome, <italic>SOD</italic> sulfite oxidase deficiency</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Neuroimaging findings that may facilitate the diagnosis of neonatal disorders with cerebellar involvement</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Neuroimaging finding</th><th>Diseases</th></tr></thead><tbody><tr><td colspan="2">Calcifications</td><td>AGS, CMV, CS</td></tr><tr><td colspan="2">Callosal agenesis/dysgenesis</td><td>CII, CMD, NKH, SLO</td></tr><tr><td colspan="2">Cerebellar atrophy (global)</td><td>AGS, CDG, CNCL, CS</td></tr><tr><td colspan="2">Cerebellar cysts</td><td>CMD, PCH1/2/6</td></tr><tr><td rowspan="3">Cerebellar hemispheres</td><td>Atrophy</td><td>Preterm disruption, PCH</td></tr><tr><td>Dysplasia</td><td>CMD</td></tr><tr><td>Hypoplasia</td><td>DWM, PCH</td></tr><tr><td colspan="2">Cerebral atrophy</td><td>AGS, CNCL, CS</td></tr><tr><td colspan="2">Dentate nuclei T2-hyperintense signal</td><td>Krabbe</td></tr><tr><td colspan="2">Global cerebellar hypoplasia</td><td>BD, CDG, CMV, NKH, SOD, SLO</td></tr><tr><td colspan="2">Global cerebral edema</td><td>SOD, HII</td></tr><tr><td colspan="2">Malformation of cortical development</td><td>CMD, CMV, JS</td></tr><tr><td colspan="2">Molar tooth sign</td><td>JS</td></tr><tr><td colspan="2">Pontine hypoplasia</td><td>CII, CDG, CMD, preterm disruption, JS, PCH, PTCD</td></tr><tr><td rowspan="2">Posterior fossa</td><td>Small</td><td>CII</td></tr><tr><td>Enlarged</td><td>DWM</td></tr><tr><td colspan="2">Tectal abnormality</td><td>CII, CMD, JS, RES</td></tr><tr><td rowspan="4">Vermis</td><td>Agenesis</td><td>RES, Teratogens</td></tr><tr><td>Atrophy</td><td>Preterm disruption, PCH</td></tr><tr><td>Dysplasia</td><td>CMD, JS</td></tr><tr><td>Hypoplasia</td><td>DWM, JS, PCH, PTCD</td></tr><tr><td colspan="2">Ventriculomegaly</td><td>Cerebellar hemorrhage, CII, CMD, CMV, DWM, RES, SLO, sinovenous thrombosis, tumor</td></tr><tr><td rowspan="2">White matter signal abnormality</td><td>Cerebellar</td><td>AGS, CS, Krabbe, MSUD, NKH, PDH, PMD</td></tr><tr><td>Cerebral</td><td>AGS, CMV, CMD, CS, Krabbe, MSUD<sup>a</sup>, NKH<sup>a</sup>, PMD</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>only myelinated white matter tracts, <italic>AGS</italic> Aicardi-Goutières syndrome, <italic>BD</italic> brainstem disconnection, <italic>CDG</italic> congenital disorders of glycosylation, <italic>CII</italic>, Chiari type II malformation, <italic>CMD</italic> congenital muscular dystrophy, <italic>CMV</italic> cytomegalovirus infection, <italic>CNCL</italic> congenital neuronal ceroid lipofuscinosis, <italic>CS</italic> Cockayne syndrome, <italic>DWM</italic> Dandy-Walker malformation, <italic>HII</italic> hypoxic-ischemic injury, <italic>HSV</italic> herpes simpex infection, <italic>JS</italic> Joubert syndrome, <italic>MSUD</italic> maple syrup urine disease, <italic>NKH</italic> nonketotic hyperglycinemia, <italic>PCH</italic> pontocerebellar hypoplasia, <italic>PDH</italic> pyruvate dehydrogenase deficiency, <italic>PMD</italic> Pelizaeus-Merzbacher disease, <italic>PTCD</italic> pontine tegmental cap dysplasia, <italic>RES</italic> rhombencephalosynapsis, <italic>SLO</italic> Smith-Lemli-Opitz syndrome, <italic>SOD</italic> sulfite oxidase deficiency</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec2">
<title>Inherited cerebellar lesions</title>
<sec id="Sec3">
<title>Cerebellar malformations</title>
<sec id="Sec4">
<title>Dandy-Walker malformation (DWM)</title>
<p>DWM is the most common posterior fossa malformation. It mainly occurs sporadically and has a low recurrence risk. DWM may be isolated or part of chromosomal anomalies or Mendelian disorders. Recent genetic studies suggested that DWM may be caused by signaling defects affecting the cerebellum and its overlying mesenchyme.</p>
<p>The dominant clinical feature of DWM is the occurrence of hydrocephalus, that typically develops during infancy [<xref ref-type="bibr" rid="CR5">5</xref>]. Because of the progress and increasing availability of prenatal MRI, an increasing number of cases are being diagnosed in utero and during the neonatal period even in the absence of hydrocephalus. Neonates with syndromic DWM such as those with Ritscher-Schinzel syndrome or Ellis-van Creveld syndrome may present due to associated extracerebellar or systemic abnormalities.</p>
<p>DWM is defined by neuroimaging findings including hypoplasia, elevation, and anticlockwise rotation of the vermis and cystic dilatation of the fourth ventricle. The dilated fourth ventricle extends posteriorly filling nearly the entire posterior fossa [<xref ref-type="bibr" rid="CR6">6</xref>]. Elevation of tentorium and torcula, enlargement of the posterior fossa, hydrocephalus, brainstem hypoplasia, and supratentorial malformations may be present.</p>
<p>Correction of hydrocephalus is the main treatment in DWM. Shunt placement within the lateral ventricles and/or posterior fossa cyst is currently considered the surgical treatment of choice. The long-term outcome is variable. Abnormal vermian lobulation and additional brain malformations are unfavorable predictors of cognitive outcome [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p>DWM is defined by the cerebellar involvement. While cerebellar involvement is unlikely to be responsible for the neonatal presentation, it plays an important role in clinical symptoms/findings later in life, including ataxia (present in 30–40 % patients with DWM) and cognitive dysfunction.</p>
</sec>
<sec id="Sec5">
<title>Joubert syndrome (JS)</title>
<p>JS has an estimated prevalence of 1:80,000, is almost always inherited with an autosomal-recessive pattern, and is caused by mutations in more than 30 genes coding for proteins of the primary cilia [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>].</p>
<p>JS may present during the neonatal period [<xref ref-type="bibr" rid="CR10">10</xref>]. Hypotonia of variable severity is present in almost all patients. An abnormal breathing pattern including tachypnea (up to 200 breaths per minute) intermixed with apnea occurs in approximately 30 % of patients. This respiratory instability improves over time, and disappears spontaneously within the first 2 years of life. Recently, we reported that head titubation is a benign, early presentation of JS [<xref ref-type="bibr" rid="CR11">11</xref>]. Head titubation is horizontal, presents within the first 2 months of life only when children are awake, and decreases in severity over time until it spontaneously resolves. A variety of craniofacial dysmorphic features may also be present in JS including prominent forehead, high rounded eyebrows, epicanthal folds, and open mouth. Systemic abnormalities including colobomas, retinal dystrophy, renal cysts, and polydactyly are also found during the neonatal period. The presence of enoral findings (e.g. tongue hamartoma, additional frenula, and upper lip notch) and/or mesoaxial polydactyly allows the diagnosis of oral-facial-digital syndrome type VI, a phenotype of JS. Ataxia, ocular motor apraxia, and intellectual disability are common features in JS that develop later in life.</p>
<p>JS is defined by the presence of the molar tooth sign (MTS) on axial neuroimaging. The MTS is characterized by elongated, thickened, and horizontally orientated superior cerebellar peduncles and a deep interpeduncular fossa (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>-<xref ref-type="fig" rid="Fig1">c</xref>). Hypoplasia and dysplasia of the cerebellar vermis is another consistent finding. The spectrum of neuroimaging findings extends beyond the MTS and vermian hypo-dysplasia, and may include a variety of infra- and supratentorial findings [<xref ref-type="bibr" rid="CR12">12</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>
<bold>a</bold>, Sagittal, <bold>b</bold>, Axial, and <bold>c</bold>, Coronal T2-weighted MR images of a 2-day-old term male newborn with Oral-Facial-Digital syndrome type VI (a phenotype of Joubert syndrome) show severe hypoplasia of the cerebellar vermis and both cerebellar hemispheres, the characteristic molar tooth sign including thickened and elongated superior cerebellar peduncles and a deepened interpeduncular fossa, and a hypothalamic hamartoma (arrows)(reprinted with permission from Poretti A et al., AJNR Am J Neuroradiol, 2008;29:1090–91). <bold>d</bold>, Sagittal, <bold>e</bold>, Axial, and <bold>f</bold>, Coronal T2-weighted MR images of a 5-day-old term male neonate with rhombencephalosynapsis reveal continuity of the cerebellar hemispheres, dentate nuclei, and superior cerebellar peduncles without a midline intervening vermis. On the sagittal image, no primary fissure is seen. In addition, dysplasia of the tectal plate, obstruction of the Sylvian aqueduct at the level of the inferior colliculi, and marked supratentorial hydrocephalus. Note that the dentate nucleus is visible on a midsagittal image, while in normal anatomy the vermis separates the dentate nuclei in the midline</p></caption><graphic id="MO1" xlink:href="40673_2016_39_Fig1_HTML"></graphic></fig></p>
<p>The long-term outcome of JS is variable. A small number of children may die in the neonatal period or infancy for unknown causes (possibly related to breathing abnormalities). Intellectual disability is present in almost all patients, but there is a broad spectrum of severity. Liver and renal involvement may cause high morbidity and mortality and needs appropriate work-up and regular follow-up.</p>
<p>In JS, cerebellar involvement allows for early diagnosis and is most likely responsible for the clinical presentation during the neonatal period.</p>
</sec>
<sec id="Sec6">
<title>Rhombencephalosynapsis (RES)</title>
<p>RES is a sporadic malformation that is most likely caused by disruption of dorsal-ventral patterning. Children with RES typically present later in life with ataxia and intellectual disability [<xref ref-type="bibr" rid="CR13">13</xref>]. RES, however, is commonly associated with hydrocephalus due to stenosis of the Sylvian aqueduct and affected children may present as newborns with congenital hydrocephalus. RES may occur in isolation or be part of the Gómez‐López‐Hernández syndrome, which is characterized by RES, parietal alopecia, trigeminal anesthesia, and craniofacial dysmorphic signs [<xref ref-type="bibr" rid="CR14">14</xref>]. Alopecia is usually bilateral, bitemporal, and present from birth.</p>
<p>RES is defined by absence of the vermis and continuity/fusion of the cerebellar hemispheres, dentate nuclei, and superior cerebellar peduncles (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>-<xref ref-type="fig" rid="Fig1">f</xref>) [<xref ref-type="bibr" rid="CR15">15</xref>]. RES may be associated with other brain anomalies such as hydrocephalus, tectal dysplasia, and callosal dysgenesis.</p>
<p>The long-term cognitive outcome is variable ranging from normal cognitive function to severe intellectual disability. Severe RES with associated tectal dysplasia and other cerebral anomalies is a predictor of poor cognitive outcome.</p>
<p>In RES, cerebellar involvement allows the diagnosis. However, it is not likely to be responsible for the neonatal presentation, but may plays a role in clinical symptoms/findings later in life (ataxia) and impaired cognition.</p>
</sec>
<sec id="Sec7">
<title>Pontocerebellar hypoplasias (PCHs)</title>
<p>PCHs are a group of autosomal recessive neurodegenerative disorders with a prenatal onset [<xref ref-type="bibr" rid="CR16">16</xref>]. To date, 10 subtypes with different phenotypes and genotypes have been identified. Some forms of PCH present during the neonatal period [<xref ref-type="bibr" rid="CR16">16</xref>]. PCH1 is characterized by loss of motor neurons in the anterior horn of the spinal cord resulting in severe hypotonia, weakness, dysphagia, and respiratory insufficiency [<xref ref-type="bibr" rid="CR17">17</xref>]. In PCH2, neonatal presentation includes impairment of swallowing, jitteriness, and dystonia [<xref ref-type="bibr" rid="CR17">17</xref>]. PCH4 has a severe neonatal course with hypertonia, congenital contractures, and primary hypoventilation requiring prolonged mechanical ventilation [<xref ref-type="bibr" rid="CR18">18</xref>]. PCH6 is characterized by neonatal encephalopathy with dysphagia, seizures, generalized hypotonia, and progressive microcephaly [<xref ref-type="bibr" rid="CR19">19</xref>]. Developmental milestones are not reached. Lactic acidemia and elevated lactate in the cerebrospinal fluid have been found in patients with PCH6 due to reduced activity of mitochondrial complexes I, III, and IV.</p>
<p>The cerebellar abnormality in PCH is characterized by ponto-cerebellar hypoplasia and progressive atrophy with prenatal onset [<xref ref-type="bibr" rid="CR20">20</xref>]. In some cases of PCH (particularly type 2 due to <italic>TSEN54</italic> mutations) there is more severe involvement of the cerebellar hemispheres compared to the vermis. On coronal T2-weighted images, this pattern has a “dragonfly” appearance that is created by flattened cerebellar hemispheres (the “wings”) and a relatively preserved cerebellar vermis (the “body”). Absence or significant reduction of the pontine prominence is characteristic of prenatal onset in PCH. In PCH4, the cerebellar vermis is more severely affected compared to the hemispheres.</p>
<p>The long-term outcome is variable and depends on the underlying type of PCH. In PCH, the cerebellar and brainstem involvement may suggest the diagnosis that subsequently needs to be confirmed by genetic analysis. It is unclear how the cerebellar involvement may explain the clinical features, however brainstem involvement may be partially responsible for the movement disorders reported in PCH.</p>
</sec>
<sec id="Sec8">
<title>Congenital muscular dystrophies due to α-dystroglycanopathy</title>
<p>The α-dystroglycanopathies are a group of autosomal-recessive congenital muscular dystrophies resulting from mutations in more than 15 genes responsible for the O-glycosylation of α-dystroglycan [<xref ref-type="bibr" rid="CR21">21</xref>]. The muscles, brain, and eyes are usually affected. Based on the severity of findings, various phenotypes have been described including Fukuyama disease, muscle-eye-brain disease, and Walker-Warburg syndrome, which is the most severe form [<xref ref-type="bibr" rid="CR22">22</xref>]. Neonatal presentation is typical and includes weakness with predominant involvement of the proximal muscles, hypotonia, contractures, seizures, and macrocephaly [<xref ref-type="bibr" rid="CR23">23</xref>]. Eye involvement is variable and may include retinal dysplasia and dystrophy, glaucoma, microophthalmia, and cataracts. Typically, creatine kinase is markedly elevated.</p>
<p>On neuroimaging, neonatal infratentorial involvement is characterized by cerebellar hypo-dysplasia, pontine hypoplasia, ventral pontine cleft, and ponto-mesencephalic kinking. Multiple small cortical/subcortical cerebellar cysts are common in muscle-eye-brain disease and Fukuyama disease, but develop only in the first months of life [<xref ref-type="bibr" rid="CR24">24</xref>]. Supratentorial involvement is variable and ranges from mild ventriculomegaly, diffuse periventricular white matter changes, and focal areas of polymicrogyria to severe hydrocephalus, generalized white matter signal changes, and diffuse cortical abnormalities, including cobblestone lissencephaly [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
<p>The long-term outcome is variable and depends on the underlying phenotype (e.g. Fukuyama disease has the most favorable outcome) and genotype.</p>
<p>In α-dystroglycanopathies, the cerebellar and brainstem involvement associated with the cerebral anomalies and clinical findings may suggest the diagnosis that then needs to be confirmed by genetic analysis or muscle biopsy. The clinical presentation is most likely explained by the cerebral, muscle, and eye involvement, while the role of the cerebellar involvement in the clinical presentation remains unclear.</p>
</sec>
<sec id="Sec9">
<title>Pontine tegmental cap dysplasia (PTCD)</title>
<p>PTCD is a rare sporadic brainstem malformation with unknown genotype and no familial recurrence and most likely results from abnormal axonal guidance and/or neuronal migration.</p>
<p>Children with PTCD may present in the neonatal period with hearing loss, facial paralysis, trigeminal anesthesia, dysphagia, and reduced opening of the mouth [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Systemic involvement with vertebral segmentation anomalies, rib malformations, and congenital heart defects has been observed.</p>
<p>The neuroimaging findings are pathognomonic and include a flattened ventral pons, vaulted pontine tegmentum (the “cap”), partial absence of the middle cerebellar peduncles, absence of the inferior cerebellar peduncles, vermian hypoplasia, a molar tooth-like aspect of the ponto-mesencephalic junction, and absent inferior olivary prominence [<xref ref-type="bibr" rid="CR25">25</xref>]. The degree of brainstem dysplasia seems to correlate with the developmental disability.</p>
<p>The intellectual prognosis appears to be highly variable, ranging between mild cognitive delay to severe disability.</p>
<p>In PTCD, the brainstem involvement is diagnostic and responsible for the clinical presentation.</p>
</sec>
<sec id="Sec10">
<title>Brainstem disconnection (BD)</title>
<p>BD is an extremely rare abnormality of unknown etiology. All children are symptomatic at birth. The clinical manifestations are characterized by brainstem dysfunction including absent or weak sucking and swallowing, absent or markedly insufficient breathing in the majority of patients, increased or decreased muscle tone, and reduced or poor visual fixation [<xref ref-type="bibr" rid="CR27">27</xref>]. Seizures and unstable body temperature may occur.</p>
<p>BD is defined by the characteristic neuroimaging pattern including nearly complete absence of a brainstem segment with the intact rostral and caudal portions connected only by a thin cord of tissue on neuroimaging [<xref ref-type="bibr" rid="CR27">27</xref>]. BD is usually associated with cerebellar hypoplasia. Supratentorial abnormalities are unusual. In the majority of the patients, the basilar artery is missing.</p>
<p>The majority of children die within the first 2 months of life. Nasogastric tube or gastrostomy, intubation and mechanical ventilation, and temperature management systems are needed to treat the swallowing disorders, respiratory insufficiency, and episodic hyperthermia these infants have.</p>
<p>In BD, the brainstem involvement is diagnostic and responsible for the clinical presentation.</p>
</sec>
<sec id="Sec11">
<title>Chiari type II malformation (CII)</title>
<p>CII is not a cerebellar malformation, but a spinal dysraphism with secondary morphological anomalies of the posterior fossa contents. Nevertheless, we decided to include CII in this group of diseases. CII occurs in about 1 of 1000 live births and is universally associated with non skin-covered myelomeningocele/spinal dysraphia [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
<p>Affected neonates are symptomatic during the neonatal period due to spinal involvement and hydrocephalus. Clinical features of CII related to cerebellar and brainstem anomalies, are present in approximately 30 % of neonates, and include dysphagia, vocal cord paralysis with laryngeal stridor, and central or obstructive ventilation abnormalities with apneic episodes. The presence of stridor, apnea, cyanotic spells, and dysphagia is associated with increased mortality [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
<p>CII is defined by a small posterior fossa with inferior displacement of the lower cerebellum, medulla, and fourth ventricle through the foramen magnum [<xref ref-type="bibr" rid="CR28">28</xref>]. Hydrocephalus is present in up to 90 % of affected neonates and is caused by the hindbrain malformation that blocks/impairs the cerebrospinal fluid hydro-dynamics of the posterior fossa or by aqueductal stenosis. Additional morphological abnormalities include beaking of the tectal plate, pontine hypoplasia, callosal dysgenesis, large massa intermedia, and cortical malformations [<xref ref-type="bibr" rid="CR30">30</xref>].</p>
<p>Intrauterine surgical repair of the myelomeningocele between 19 and 25 weeks of gestation has been shown to reduce the rate of shunt placement, improve motor function at 30 months, and decrease severity of hindbrain herniation [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>].</p>
<p>In CII, the cerebellar and brainstem findings are diagnostic and partially responsible for the clinical presentation.</p>
</sec>
</sec>
<sec id="Sec12">
<title>Neurometabolic disorders with neonatal cerebellar involvement</title>
<sec id="Sec13">
<title>Congenital disorders of glycosylation (CDG)</title>
<p>CDG include nearly 50 inborn errors of glycan metabolism with an estimated prevalence of 1:20,000 [<xref ref-type="bibr" rid="CR33">33</xref>]. This rapidly growing group of disorders encompasses defects in N-glycosylation, O-glycosylation, and lipid-linked glycosylation. The most common congenital disorder of glycosylation is phosphomannomutase II deficiency (PMM2-CDG) [<xref ref-type="bibr" rid="CR33">33</xref>].</p>
<p>In these diseases, there is significant phenotypic diversity. Classically babies present with multi-system involvement including abnormal fat distribution, inverted nipples, hypotonia, hyporeflexia, and strabismus [<xref ref-type="bibr" rid="CR33">33</xref>]. Ataxia may develop in some patients. In PMM2-CDG, brain MRI may be normal, however, MRI often reveals significant pontocerebellar hypoplasia and superimposed cerebellar atrophy and T2-hyperintense signal of the cerebellar cortex [<xref ref-type="bibr" rid="CR34">34</xref>]. Cerebellar atrophy and T2-hyperintense signal of the cerebellar cortex are typically not present in the neonatal period, but may develop later.</p>
<p>In CDG, pontocerebellar hypoplasia may suggest the diagnosis, which must then be confirmed by transferrin electrophoresis and genetic analysis. Pontocerebellar hypoplasia may explain the occurrence of ataxia in CDG. Treatment for most CDG remains symptomatic and palliative. The prognosis of CDG is variable and depends on the underlying phenotype and genotype.</p>
</sec>
<sec id="Sec14">
<title>Smith-Lemli-Opitz syndrome (SLO)</title>
<p>SLO has an estimated prevalence of around 1:20,000–40,000 births and results from abnormal cholesterol biosynthesis [<xref ref-type="bibr" rid="CR35">35</xref>]. Patients typically have dysmorphic features, which can include a broad nasal bridge, anteverted nares, and long philtrum. Skeletal abnormalities are common and most patients have syndactyly of the 2nd and 3rd toes. A variety of systems can be involved and neonates can have cardiovascular, gastrointestinal, renal, and genitourinary abnormalities. Neurologic manifestations include congenital microcephaly, ptosis, and hypotonia [<xref ref-type="bibr" rid="CR35">35</xref>]. Structural brain abnormalities are seen in about one-third of patients and include ventriculomegaly, hypoplastic frontal lobes, absent or hypoplastic corpus callosum, and, in some patients, cerebellar hypoplasia [<xref ref-type="bibr" rid="CR36">36</xref>].</p>
<p>The diagnosis of SLO is based on the detection of elevated 7-dehydrocholesterol in blood or tissues and can be confirmed by mutation analysis. The blood cholesterol level is not a reliable screening test. Management is symptomatic. Long-term outcome is variable and depends on the severity of the disease and associated malformations. Cardiovascular and brain malformations may be lethal.</p>
<p>Cerebellar involvement with global cerebellar hypoplasia is inconsistently present and non-specific.</p>
</sec>
<sec id="Sec15">
<title>Nonketotic hyperglycinemia (NKH)</title>
<p>NKH has an estimated prevalence of around 1:55,000–65,000 births and results from a deficiency in glycine cleavage with subsequent toxic systemic accumulation of glycine. Central nervous system toxicity results and infants typically present in the first 2 days of life with depressed alertness, hypotonia, myoclonic jerks, and refractory seizures. Many progress quickly to apnea, coma, and death [<xref ref-type="bibr" rid="CR37">37</xref>]. EEG commonly reveals a burst suppression pattern. Early neuroimaging findings include restricted diffusion of myelinated white matter tracks (including cerebellar and brainstem white matter tracts), agenesis of the corpus callosum, and a glycine peak on <sup>1</sup>H-MR-spectroscopy [<xref ref-type="bibr" rid="CR36">36</xref>]. Hypoplasia of the cerebellar vermis is seen in a minority of patients [<xref ref-type="bibr" rid="CR37">37</xref>].</p>
<p>The diagnosis is established by an increase in CSF glycine concentration and an increased CSF-to-plasma glycine ratio, and can be confirmed by genetic analysis.</p>
<p>Sodium benzoate may be used to reduce plasma glycine levels. Otherwise management is primarily symptomatic. Long-term outcome is usually poor and early death may occur due to apnea.</p>
<p>Cerebellar involvement with vermis hypoplasia is inconsistently present and non-specific. <sup>1</sup>H-MR-spectroscopy showing a glycine peak may facilitate the diagnosis of NKH.</p>
</sec>
<sec id="Sec16">
<title>Maple syrup urine disease (MSUD)</title>
<p>MSUD is an autosomal recessive condition that results from a deficiency in branched-chain α-ketoacid dehydrogenase enzyme and causes an accumulation of leucine, isoleucine, and valine. Leucine and its byproducts exert the primary neurotoxic effects resulting in intramyelinic edema. MSUD has an estimated prevalence of 1:150,000 live births.</p>
<p>Neonates typically present in the first week of life with poor feeding, recurrent emesis, lethargy, fluctuating ophthalmoplegia, and seizures [<xref ref-type="bibr" rid="CR38">38</xref>]. Many newborns develop dystonia and stereotyped, “bicycling” or “fencing” movements of the extremities [<xref ref-type="bibr" rid="CR38">38</xref>]. During the acute phase of deterioration, neuroimaging shows T2-hyperintense signal and decreased diffusion of the cerebellar and other white matter regions that are already myelinated (Fig. <xref ref-type="fig" rid="Fig2">2</xref>) [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR39">39</xref>].<fig id="Fig2"><label>Fig. 2</label><caption><p>
<bold>a</bold>-<bold>c</bold>, Axial T2-weighted MR images of a 20-day-old male term neonate with maple syrup urine disease show swelling and hyperintense signal of the cerebellar white matter, dorsal pons, corticospinal tracts along its course in the basis pontis, midbrain, and posterior limbs of the internal capsule, and thalami. <bold>d</bold>-<bold>f</bold>, Trace of diffusion images and <bold>g-i</bold>, Apparent diffusion coefficient (ADC) maps of the same newborn reveal bright DWI-signal and matching low ADC values, respectively, in the cerebellar white matter, dorsal pons, corticospinal tracts in the basis pontis, midbrain, and posterior limb of the internal capsule, and thalami representing restricted diffusion/cytotoxic edema compatible with extensive ongoing injury to the myelinated parts of the brain</p></caption><graphic id="MO2" xlink:href="40673_2016_39_Fig2_HTML"></graphic></fig></p>
<p>The diagnosis is confirmed by detecting increased values of branched-chain amino acids (leucine, isoleucine, and valine) and branched-chain keto-acids in blood and urine. Early diagnosis is paramount for a favorable long-term outcome; children may be able to achieve a normal cognitive outcome if appropriate intervention (diet) occurs early in the neonatal course [<xref ref-type="bibr" rid="CR40">40</xref>].</p>
<p>In MSUD, cerebellar involvement on neuroimaging is distinctive and may be helpful in establishing an early diagnosis.</p>
</sec>
<sec id="Sec17">
<title>Pyruvate dehydrogenase deficiency (PDH)</title>
<p>PDH results from mutations in the pyruvate dehydrogenase complex, which is responsible for the conversion of pyruvate to acetyl-CoA. In the neonatal form, patients typically present with hypotonia, encephalopathy, microcephaly, and tachypnea [<xref ref-type="bibr" rid="CR41">41</xref>]. Approximately one-third develop seizures. MRI findings include dysgenesis of the corpus callosum, mega cisterna magna, heterotopias, pachygyria and cortical atrophy. T2-hyperintense signal and decreased diffusion can occur in the cerebellar white matter, posterior limb of the internal capsule, and occipital lobes. <sup>1</sup>H-MR-spectroscopy may reveal a doublet peak at 1.3 ppm compatible with lactate [<xref ref-type="bibr" rid="CR36">36</xref>].</p>
<p>Lactate is typically elevated in the blood and CSF. The diagnosis is suspected by abnormal enzyme function and can be confirmed by genetic analysis. Treatment typically includes cofactor supplementation (e.g. thiamine and carnitine) and ketogenic diet. Long-term outcome is generally poor.</p>
<p>Cerebellar involvement with T2-hyperintense signal and restricted diffusion in the cerebellar white matter is non-specific.</p>
</sec>
<sec id="Sec18">
<title>Sulfite oxidase deficiency (SOD)</title>
<p>Isolated SOD and SOD due to molybdenum cofactor deficiency result in the accumulation of sulfites, which are toxic to the developing brain [<xref ref-type="bibr" rid="CR42">42</xref>]. SOD may present with poor feeding, emesis and seizures [<xref ref-type="bibr" rid="CR43">43</xref>]. The onset of seizures is typically accompanied by rapid neurologic deterioration [<xref ref-type="bibr" rid="CR44">44</xref>]. Dysmorphic features are present in up to 75 % of patients, including coarse facies, small nose, elongated face, and long philtrum [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Ectopia lentis is present later in the disease course [<xref ref-type="bibr" rid="CR43">43</xref>]. Initial neuroimaging with MRI reveals generalized white matter edema, mimicking hypoxic ischemic injury [<xref ref-type="bibr" rid="CR36">36</xref>].</p>
<p>The diagnosis is based on high sulfite, thiosulfate, S-sulfocysteine, and taurine concentrations in urine and should be confirmed by genetic analysis. The long-term outcome is usually poor including intractable seizures and death in early infancy. Substitution therapy with purified cyclic pyranopterin monophosphate is a new, promising causative therapy for molybdenum cofactor deficiency [<xref ref-type="bibr" rid="CR45">45</xref>].</p>
<p>Cerebellar involvement with global cerebellar hypoplasia is inconsistently present and non-specific [<xref ref-type="bibr" rid="CR36">36</xref>].</p>
</sec>
</sec>
<sec id="Sec19">
<title>Neurodegenerative disorders with neonatal cerebellar involvement</title>
<sec id="Sec20">
<title>Krabbe disease (KD)</title>
<p>KD has an estimated prevalence of 1:100,000 and is caused by deficiency of the lysosomal enzyme galactocerebrosidase and is characterized by failure of myelination in the central and peripheral nervous systems [<xref ref-type="bibr" rid="CR46">46</xref>]. Neonatal presentation of KD is characterized by spasticity, marked irritability, and lack of motor development [<xref ref-type="bibr" rid="CR47">47</xref>]. Neuroimaging shows signal abnormalities of the lateral thalami, corona radiata, cerebellar white matter, and dentate nuclei.</p>
<p>In KD, cerebellar involvement is characteristic and may suggest the diagnosis, which needs to be confirmed by low galactocerebrosidase activity in peripheral leukocytes and genetic analysis. Treatment is symptomatic. Long-term prognosis is poor and neurodegeneration and early death occurs within the first 2–3 years of life.</p>
</sec>
<sec id="Sec21">
<title>Cockayne syndrome (CS)</title>
<p>CS is a nucleotide excision repair disease with an estimated prevalence of 1:200,000. CS may present during the neonatal period (CS type II) with prenatal and postnatal growth failure, congenital cataracts, loss of adipose tissue, joint contractures, and distinctive face with small, deep-set eyes and prominent nasal bridge [<xref ref-type="bibr" rid="CR48">48</xref>]. Myelination is disturbed within the central and peripheral nervous system. Additional brain involvement includes basal ganglia calcifications and severe cerebral and cerebellar atrophy.</p>
<p>In CS type II, cerebellar atrophy is a non-specific finding. The entire clinical and imaging findings may suggest the diagnosis that needs confirmation by genetic analysis.</p>
<p>Management is supportive and the progressive course leads typically to death before the end of the first decade.</p>
</sec>
<sec id="Sec22">
<title>Pelizaeus-Merzbacher disease (PMD)</title>
<p>PMD is a hypomyelinating disorder that is caused by <italic>PLP1</italic> mutations and has an estimated prevalence of 1:400,000 [<xref ref-type="bibr" rid="CR49">49</xref>]. PMD may present during the neonatal period (connatal PMD) with hypotonia, inspiratory stridor, horizontal or rotatory nystagmus, and seizures. Neuroimaging shows near complete absence of central nervous system myelin including brainstem and cerebellar white matter tracts (Fig. <xref ref-type="fig" rid="Fig3">3</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>
<bold>a</bold>-<bold>c</bold>, Axial T2-weighted MR images of a 5-day-old male term neonate with genetically confirmed Pelizaeus-Merzbacher disease presenting with marked muscular hypotonia, rotatory nystagmus, and inspiratory stridor show a homogeneous increased hyperintense signal of the supra- and infratentorial white matter including the corticospinal tracts within the posterior limb of the internal capsule bilaterally compatible with hypomyelination</p></caption><graphic id="MO3" xlink:href="40673_2016_39_Fig3_HTML"></graphic></fig></p>
<p>In PMD, complete absence of myelin within the brainstem and cerebellar white matter associated with the clinical findings may suggest the diagnosis, which then needs to be confirmed by genetic analysis. Management is symptomatic. PMD has a progressive course leading to death by the second decade.</p>
</sec>
<sec id="Sec23">
<title>Aicardi-Goutières syndrome (AGS)</title>
<p>AGS is a genetically heterogeneous inflammatory disease and is an important diagnostic consideration in neonates with imaging findings suggestive of perinatal infection. AGS is consistently associated with an interferon signature, which is sustained over time and can be used for diagnostic purposes. Newborns with AGS classically have intracranial calcifications, white matter abnormalities, and cerebral atrophy. Calcifications can be seen in the dentate nuclei in approximately 30 % of affected children [<xref ref-type="bibr" rid="CR50">50</xref>]. In addition, cerebellar atrophy has been reported inconsistently as a late feature.</p>
<p>In AGS, dentate nuclei calcifications as well as other neuroimaging findings and clinical features may suggest the diagnosis that needs confirmation by genetic analysis. Treatment is symptomatic and the majority of patients presenting early in life die within the first 10 years of life.</p>
</sec>
<sec id="Sec24">
<title>Congenital neuronal ceroid lipofuscinosis (CNCL)</title>
<p>CNCL is a rare neurodegenerative disease caused by mutations in the <italic>Cathepsin D</italic> gene [<xref ref-type="bibr" rid="CR51">51</xref>]. The neonatal presentation is severe and includes therapy-resistant seizures, respiratory insufficiency, and marked microcephaly. Neuroimaging findings are characterized by severe cerebral and cerebellar atrophy. Absence of electro-retinographic responses and iso-electric electroencephalography are characteristic.</p>
<p>In CNCL, severe neonatal cerebellar atrophy associated with the above imaging and clinical findings may suggest the diagnosis that then needs to be confirmed by genetic analysis. The neonatal clinical features are most likely caused by severe cerebral atrophy. Failure of neurological development and development of a vegetative state are usually followed by death within the first weeks of life.</p>
</sec>
</sec>
<sec id="Sec25">
<title>Spinocerebellar ataxias (SCAs) with neonatal cerebellar involvement</title>
<p>SCAs are a clinically heterogeneous group of disorders with a global prevalence of 1–4/100.000 [<xref ref-type="bibr" rid="CR52">52</xref>]. More than 40 different types of SCAs have been described and they are inherited with an autosomal-dominant pattern [<xref ref-type="bibr" rid="CR53">53</xref>]. Various SCAs types are so called trinucleotide repeat disorders that are mostly caused by expansions of CAG repeats. SCAs typically present in adults and are rare causes of childhood ataxia. In rare cases, SCA2 and SCA7 may present in the neonatal period.</p>
<p>SCA2 is caused by an expansion of a CAG trinucleotide repeat near the 5′ coding region of the <italic>ataxin 2</italic> gene on chromosome 12q24. There is an inverse correlation between the repeat size and the age of onset: full penetrance alleles are usually 37–39 in adult cases, while very large expansions of over 200 have been reported in infants [<xref ref-type="bibr" rid="CR54">54</xref>]. The neonatal presentation of SCA2 is characterized by hypotonia, absent reflexes, dysphagia, poor head control, and lack of visual fixation [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. In the first year of life, infants with SCA2 usually develop developmental delay or regression, progressive encephalopathy, optic atrophy, retinitis pigmentosa, and seizures [<xref ref-type="bibr" rid="CR54">54</xref>–<xref ref-type="bibr" rid="CR56">56</xref>]. Neuroimaging findings typically include cerebellar atrophy, mild reduction in size of the pons, and progressive volume loss of the cerebral white matter with secondary ventriculomegaly and thinning of the corpus callosum, but brain MRI may reveal normal findings [<xref ref-type="bibr" rid="CR54">54</xref>].</p>
<p>SCA7 is caused by expansion of a CAG trinucleotide repeat in the first coding exon of the <italic>ataxin 7</italic> gene located on chromosome 3p. There is an inverse correlation between the size of the repeat and age of onset. The adult and childhood phenotype is characterized by visual loss due to retinitis pigmentosa, progressive ataxia, dysmetria, intention tremor, dysarthria, dysphagia, and brisk reflexes. The neonatal phenotype is quite different and includes failure to thrive, weight loss, weakness, hypotonia, and acquired microcephaly [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Patients may have a patent ductus arteriosus and evidence of multiple organ failure. In the first year of age, infant with SCA7 may develop neurological deterioration and retinal dystrophy. Neuroimaging findings are characterized by cerebellar and cerebral atrophy with secondary ventriculomegaly.</p>
</sec>
<sec id="Sec26">
<title>Acquired cerebellar lesions</title>
<sec id="Sec27">
<title>Disruption of cerebellar development in preterms</title>
<p>Cerebellar injuries in premature infants may be grouped into two categories: 1) primarily destructive injuries including hemorrhage and ischemia (as discussed later) and 2) injuries primarily impairing cerebellar development [<xref ref-type="bibr" rid="CR59">59</xref>]. The latter may represent the most common type of cerebellar abnormality of the premature infant. Two pathomechanisms are possible: 1) direct effects on the rapidly growing/developing cerebellum and 2) remote effects through altered trophic trans-synaptic interactions.</p>
<p>Direct effects on the growing cerebellum may include hypoxic-ischemic injury or toxic effect of glucocorticoids (as discussed later), blood products, and undernutrition. In preterm neonates with intraventricular hemorrhages, hemosiderin deposition on the cerebellar surface and a progressive reduction in size of cerebellum (particularly the cerebellar hemispheres) and pons may occur [<xref ref-type="bibr" rid="CR60">60</xref>]. Hemosiderin is likely toxic for the granule precursor cells of the external granular layer and their impaired survival and/or proliferation may cause cerebellar underdevelopment [<xref ref-type="bibr" rid="CR59">59</xref>].</p>
<p>Remote trans-synaptic effects that primarily affect neuronal connections between cerebrum and cerebellum may lead to cerebellar underdevelopment in preterm neonates [<xref ref-type="bibr" rid="CR61">61</xref>]. Disruption of cerebellar development in preterm neonates is frequently associated with contralateral periventricular leukomalacia (PVL) and other cerebral lesions raising the possibility that cerebellar underdevelopment may be secondary to the loss of supratentorial white matter. Unilateral cerebral brain injuries are associated with significantly decreased volume of the contralateral cerebellar hemisphere. Conversely, unilateral cerebellar injuries are associated with significantly decreased volume in specific regions of the contralateral cerebral hemisphere (dorsolateral prefrontal, premotor, sensorimotor, and midtemporal gray and white matter) [<xref ref-type="bibr" rid="CR62">62</xref>]. In addition, infants with bilateral diffuse PVL typically have symmetric bilateral decreases in cerebellar volume.</p>
<p>In the neonatal period, the cerebellar abnormality is most often clinically silent, making this group of disorders difficult to diagnose. Symptoms and signs related to the direct effect of intraventricular hemorrhage or a remote cerebral injury may provide clues to the provider. Examples include seizure, bulging fontanelle, alteration of consciousness, or focal neurologic deficit.</p>
<p>On conventional MRI, following morphologic patterns of disrupted cerebellar development may be seen: 1) symmetric volume reduction of the cerebellar hemispheres and a small vermis with preserved shape (Fig. <xref ref-type="fig" rid="Fig4">4c</xref>-<xref ref-type="fig" rid="Fig4">d</xref>), 2) symmetric reduction in hemispheric volume with an enlarged, balloon-shaped fourth ventricle and a small, deformed vermis, and 3) normal overall cerebellar shape with extensive reduction of its dimensions [<xref ref-type="bibr" rid="CR60">60</xref>]. Pontine hypoplasia is consistently seen. In addition, unilateral cerebellar hypoplasia may be seen secondary to contralateral PVL.<fig id="Fig4"><label>Fig. 4</label><caption><p>
<bold>a</bold>, Ultrasonography image through the mastoid fontanel of a 14-day-old neonate born at 26 weeks of gestation show a cerebellar hemorrhage (arrows). <bold>b</bold>, Coronal T2-weighted image at 2 months of life reveals encephalomalacic changes within the right cerebellar hemisphere with T2-hypointense foci representing deposition of blood products. <bold>c</bold>, Sagittal T1- and <bold>d</bold>, Coronal T2-weighted MR images of a 3-year-old boy born at 25 weeks gestation reveal a small posterior fossa, marked reduction in the size of the cerebellar hemispheres, which have a skeletonized appearance and appear more affected compared to the small vermis. Together with the pontine hypoplasia, constellation of findings suggest disruption of the cerebellar development as a sequela of prematurity. In addition, a T2-hypointense signal is noted in the left cerebellar folia suggesting hemosiderin deposition due to remote hemorrhage. Finally, a thinned corpus callosum and encephalomalacic changes in the supratentorial brain are also seen</p></caption><graphic id="MO4" xlink:href="40673_2016_39_Fig4_HTML"></graphic></fig></p>
<p>In ex-preterm neonates with cerebellar underdevelopment, impairments in motor, cognitive, and behavioral (socialization difficulties, early autistic features) functions are highly prevalent [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Cerebellar volume has been shown to predict motor and cognitive performance in ex-preterm adolescents [<xref ref-type="bibr" rid="CR64">64</xref>].</p>
</sec>
</sec>
<sec id="Sec28">
<title>Vascular disorders of the neonatal cerebellum</title>
<sec id="Sec29">
<title>Cerebellar hemorrhages</title>
<p>Cerebellar hemorrhages are common neonatal acquired cerebellar injuries, particularly in preterm neonates. The prevalence depends on the degree of prematurity and birth weight. In a large series of cases, the prevalence of cerebellar hemorrhages was 2.7 % in preterm neonates with a birth weight above 750 g and 8.7 % in those below 750 g [<xref ref-type="bibr" rid="CR65">65</xref>].</p>
<p>Cerebellar hemorrhages typically originate from the cerebellar germinal matrix within the external granular layer that is thickest at 24 weeks of gestation and begins to involute at 30 weeks [<xref ref-type="bibr" rid="CR66">66</xref>]. Therefore, 21 through 27 weeks gestation is the most vulnerable time period for cerebellar hemorrhages. Less commonly, hemorrhages may originate in the residual germinal matrix of the ventricular zone in the roof of the fourth ventricle and primarily involve the vermis.</p>
<p>The pathogenesis of cerebellar hemorrhages is multifactorial. Different risk factors have been reported for the preterm and term neonates. In preterm neonates, maternal, intrapartum, and early postnatal characteristics are known risk factors. These include assisted conception, abnormal fetal heart rate, C-section delivery, lower Apgar scores, need for pressor support and high frequency ventilation, presence of a persistent ductus arteriosus, low pH, low plasma bicarbonate, low platelets, and low hematocrit values [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. In term neonates cerebellar hemorrhages are primarily associated with traumatic delivery [<xref ref-type="bibr" rid="CR68">68</xref>].</p>
<p>Large cerebellar hemorrhages (&gt;1 cm) may present with apnea, bradycardia, full fontanelle, or opisthotonus [<xref ref-type="bibr" rid="CR68">68</xref>]. The majority of cerebellar hemorrhages are clinically silent in the neonatal time period and require a high index of suspicion to make the diagnosis [<xref ref-type="bibr" rid="CR65">65</xref>–<xref ref-type="bibr" rid="CR67">67</xref>].</p>
<p>The traditional ultrasonographic approach through the anterior fontanelle has a low sensitivity for detecting cerebellar hemorrhages because of the echogenic tentorium and the limited penetration depth of the ultrasound waves [<xref ref-type="bibr" rid="CR65">65</xref>]. The advent of mastoid fontanel and suboccipital views significantly increased the sensitivity of ultrasonography for detection of cerebellar hemorrhage [<xref ref-type="bibr" rid="CR65">65</xref>–<xref ref-type="bibr" rid="CR67">67</xref>]. However, a high number of cerebellar hemorrhages remain undetected by ultrasonography compared to MRI [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. Brain MRI including susceptibility-weighted imaging (SWI) is the diagnostic tool of choice to detect cerebellar hemorrhages (Fig. <xref ref-type="fig" rid="Fig4">4a</xref>-<xref ref-type="fig" rid="Fig4">b</xref>).</p>
<p>Cerebellar hemorrhages occur most commonly in only one cerebellar hemisphere (71 %). The vermis is involved in 20 % of patients, and associated supratentorial lesions are found in up to 77 % of cases [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. Focal atrophy of the affected hemisphere with a secondary reduction in size of the pons may be seen approximately 2 months later in as many as 37 % of patients [<xref ref-type="bibr" rid="CR65">65</xref>]. Interestingly, significant volume reduction of the contralateral cerebral hemisphere may be present and most likely results from impaired remote trans-synaptic neurodegeneration [<xref ref-type="bibr" rid="CR65">65</xref>].</p>
<p>In preterm neonates, cerebellar hemorrhages result in high mortality (14 % compared to 1 % of control preterms) and long-term neurological morbidity (66 % compared to 5 % of control preterms) [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. Neurological sequelae include motor dysfunction in 48 % (hypotonia in 100 %, abnormal gait in 37 %, and ocular motor abnormalities in 23 %), expressive and receptive language dysfunction in 37 % to 42 %, and neurocognitive dysfunction in 40 % of children [<xref ref-type="bibr" rid="CR70">70</xref>]. Additionally, autistic features may become apparent in up to 42 %, and more than 30 % have internalizing behavioral problems. Lesions within the cerebellar hemispheres have been associated with impaired cognitive function, while injury of the cerebellar vermis may cause motor, language, and behavioral/social problems. In term neonates, the neurological sequelae are similar, but less prevalent than in preterms [<xref ref-type="bibr" rid="CR68">68</xref>].</p>
</sec>
<sec id="Sec30">
<title>Sinovenous thrombosis with cerebellar involvement</title>
<p>Cerebral sinovenous thrombosis (CSVT) affects 2.6–12/100,000 neonates and is defined by thrombosis within the superficial or deep venous system [<xref ref-type="bibr" rid="CR71">71</xref>]. In neonates, 39 % of CSVT involve the transverse sinuses, and 30 % involve the straight sinus [<xref ref-type="bibr" rid="CR72">72</xref>]. In these cases, thrombosis may lead to venous congestion and secondary venous infarction of the hemispheric white matter with or without hemorrhagic conversion of the ischemic cerebellum.</p>
<p>Generally, many risk factors for neonatal CSVT have been reported [<xref ref-type="bibr" rid="CR72">72</xref>–<xref ref-type="bibr" rid="CR74">74</xref>]. However, no specific risk factors have been reported for CSVT affecting the posterior fossa. Clinically, CSVT tends to present with seizure or decreased alertness rather than a focal neurologic sign. The presentation may be subtle and some neonates may have isolated irritability [<xref ref-type="bibr" rid="CR72">72</xref>]. No specific symptoms have been reported for CSVT affecting the cerebellum. A high index of suspicion is required to make the diagnosis.</p>
<p>Brain MRI with MR venography is the neuroimaging modality of choice [<xref ref-type="bibr" rid="CR73">73</xref>]. In addition, diffusion weighted imaging (DWI) and SWI may be helpful to identify ischemic and/or hemorrhagic complications. DWI may also be helpful to directly visualize the intravascular thrombus. A hypercoagulability evaluation should be performed to identify risk factors for future thromboses. Treatment is controversial and varies by institution; there are studies that indicate that anticoagulation may be safe, and may decrease the risk of clot propagation [<xref ref-type="bibr" rid="CR74">74</xref>].</p>
<p>Overall the outcome of CSVT is variable: 45–64 % of the affected neonates have a normal outcome, 3–19 % die, 16–18 % have seizures (higher risk with thalamic injury), and 33–65 % have neurologic deficits including both motor and cognitive deficits [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]. No specific outcomes have been reported for neonates with CSVT affecting the cerebellum.</p>
</sec>
<sec id="Sec31">
<title>Cerebellar ischemic stroke</title>
<p>In neonates, cerebellar ischemic stroke is very rare and less common than cerebellar hemorrhages [<xref ref-type="bibr" rid="CR68">68</xref>]. Some hypothesize that neonatal ischemic stroke is responsible for damage involving mostly the inferior parts of the cerebellum with secondary pontine hypoplasia in very preterm neonates [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. The consistent association of cerebellar lesions with cerebral white matter injury may suggest a similar pathogenesis of both lesions (e.g. global hypoxia/ischemia or infection/inflammation rather than vascular occlusive). Alternatively, injuries primarily impairing cerebellar development (discussed above) may be to blame.</p>
<p>In the neonatal period, ischemic cerebellar stroke is most often clinically silent, but apnea and seizures may occur. Brain MRI with DWI is the diagnostic neuroimaging modality of choice.</p>
</sec>
</sec>
<sec id="Sec32">
<title>Hypoxic-ischemic injury (HII)</title>
<p>HII affects 1–3 newborns per 1000 full-term births in the United States [<xref ref-type="bibr" rid="CR77">77</xref>]. Depending on the severity and timing of injury, four neuroimaging patterns involving cerebral cortex/white matter, usually in a parasagittal distribution, deep nuclear structures, especially putamen and thalamus, and brainstem tegmentum have been reported [<xref ref-type="bibr" rid="CR77">77</xref>]. Though literature about cerebellar involvement in HII is scant, animal models have shown that Purkinje cells are highly vulnerable to HII due to their inability to generate energy during hypoxia [<xref ref-type="bibr" rid="CR78">78</xref>]. The relative immaturity of the neonatal Purkinje cells in the cerebellar cortex is thought to have a protective effect on the cerebellar gray matter in HII [<xref ref-type="bibr" rid="CR79">79</xref>].</p>
<p>In children with HII and cerebellar involvement, clinical cerebellar signs have not been reported. This is not surprising, given neonates with cerebellar involvement typically have extensive supratentorial injuries [<xref ref-type="bibr" rid="CR80">80</xref>]. In these patients, the clinical presentation is dominated by features such as seizures and encephalopathy that result from supratentorial injury.</p>
<p>In neonatal HII, acute injury of the cerebellum is rarely depicted on conventional MRI sequences (3–4 % of the patients), but common on neuropathology exam of the brains of asphyxiated newborns who died (up to 70–80 %) [<xref ref-type="bibr" rid="CR80">80</xref>]. This difference suggests that cerebellar involvement is most likely present in neonates with severe HII. Alternatively, cerebellar injury may be subtle and difficult to identify on conventional MRI sequences. The application of diffusion tensor imaging (DTI) showed reduced factional anisotropy and increased apparent diffusion coefficient values in the cerebellar peduncles of asphyxiated neonates [<xref ref-type="bibr" rid="CR80">80</xref>]. Interestingly, all neonates who had changes in DTI scalars in the cerebellar tracts also had injury to the supratentorial brain. This supports the idea that cerebellar injury in HII occurs predominantly in severely asphyxiated neonates with cerebral injury. The association between supratentorial (particularly basal ganglia and thalami) and cerebellar abnormalities in HII has also been shown on follow-up MRI studies [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. Involvement of both 1) basal ganglia and thalami and 2) cerebellum raises the possibility that cerebellar injury in HII may be secondary to transsynaptic degeneration via the thalamo-cerebellar pathway [<xref ref-type="bibr" rid="CR81">81</xref>]. On follow-up studies in HII, selective involvement of the anterior part of the cerebellar vermis is seen as a hyperintense signal on T2-weighted images and/or selective atrophy [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. In addition, minimal subsequent growth of the cerebellar vermis has been shown in infants with HII and severe basal ganglia and thalamic lesions [<xref ref-type="bibr" rid="CR83">83</xref>]. Vermian involvement may serve as an independent predictor of severe HII associated with significant neurologic disability [<xref ref-type="bibr" rid="CR83">83</xref>].</p>
</sec>
<sec id="Sec33">
<title>Infectious etiologies with neonatal cerebellar involvement</title>
<p>Isolated cerebellar involvement in fetal and neonatal infection is rare. While cytomegalovirus infection classically results in periventricular calcifications, a number of additional brain abnormalities can be seen, including cerebellar hypoplasia (Fig. <xref ref-type="fig" rid="Fig5">5</xref>) [<xref ref-type="bibr" rid="CR84">84</xref>]. The presence of cerebellar hypoplasia suggests an early (first trimester) transmission of cytomegalovirus, which interferes with early brain development. Recently, Oosterom et al. showed that severe structural abnormalities including cerebellar hypoplasia are associated with poor neurodevelopmental outcome and/or sensorineural hearing loss [<xref ref-type="bibr" rid="CR85">85</xref>]. It is unclear, however, how much cerebellar hypoplasia may contribute to poor neurodevelopmental outcome compared to other structural abnormalities such as polymicrogyria.<fig id="Fig5"><label>Fig. 5</label><caption><p>
<bold>a</bold>, Axial computed tomography (CT) image of a 2-day-old male neonate with confirmed congenital cytomegalovirus infection shows ventriculomegaly, cerebellar hypoplasia, and periventricular hyperdense calcifications. <bold>b</bold>, Axial and <bold>c</bold>, Coronal T2-weighted MR images of the same child at the age of 14 months reveal cerebellar hypoplasia, ventriculomegaly, hyperintense signal of the periventricular white matter, hypointense periventricular calcifications, and diffuse polymicrogyria and pachygyria (reprinted with permission form Poretti A et al., Eur J Paediatr Neurol, 2009;13:397–407)</p></caption><graphic id="MO5" xlink:href="40673_2016_39_Fig5_HTML"></graphic></fig></p>
<p>Imaging findings in neonatal herpes simplex virus (HSV) encephalitis are variable. Imaging often reveals multifocal areas of diffusion restriction (cytotoxic edema); however, cases of isolated brainstem and cerebellum involvement have been described in HSV-2 [<xref ref-type="bibr" rid="CR86">86</xref>].</p>
</sec>
<sec id="Sec34">
<title>Extrinsic neurotoxic agents with neonatal cerebellar involvement</title>
<p>The neonatal cerebellum has been shown to have the highest number of glucocorticoid receptors in the brain [<xref ref-type="bibr" rid="CR87">87</xref>]. Antenatally, glucocorticoids are often given to hasten lung maturation. Postnatally, glucocorticoids may be administered for prolonged hypotension and bronchopulmonary dysplasia. Multiple animal models have demonstrated that glucocorticoids delay the growth of the cerebellum in distinct species [<xref ref-type="bibr" rid="CR88">88</xref>]. Preterm studies have demonstrated similar findings in humans, with one group reporting a 20 % reduction in cerebellar volume in patients receiving dexamethasone, as compared to control subjects [<xref ref-type="bibr" rid="CR89">89</xref>]. In one series of 172 serially imaged premature infants, postnatal betamethasone and hydrocortisone were associated with decreased cerebellar volumes of 10 % and 8 %, respectively. In the same cohort, antenatal betamethasone treatment was not associated with a change in cerebellar volume [<xref ref-type="bibr" rid="CR90">90</xref>]. A smaller cerebellar volume does not seem to affect the clinical presentation of the affected premature infants. Follow-up studies at school age are needed to detect the long-term motor and cognitive consequences of a smaller cerebellar volume due to postnatal betamethasone and hydrocortisone administration.</p>
</sec>
<sec id="Sec35">
<title>Congenital cerebellar tumors</title>
<p>Congenital brain tumors are rare and represent only 0.5–1.5 % of all pediatric brain tumors [<xref ref-type="bibr" rid="CR91">91</xref>]. Teratomas are the most frequent congenital brain tumors, while non-teratomatous neoplasms including choroid plexus papilloma, medulloblastoma, and craniopharyngioma are less common. Up to 70 % of the tumors originate within the supratentorial brain, while the remaining 30 % are located in the posterior fossa. Macrocrania is the most common presentation; the open sutures and cartilaginous character of the fetal/neonatal skull allow significant expansion in utero. Hydrocephalus, intratumoral hemorrhage, heart failure and hydrops resulting from high-cardiac output, and polyhydramnios are less common presentations. The diagnosis of a cerebellar tumor is made by a combination of conventional and advanced neuroimaging, and histological exam is needed to characterize the exact tumor type and histology. Prognosis in neonates is generally poor, but depends on the histological type, extension of the tumor, and involvement of adjacent structures.</p>
</sec>
</sec>
<sec id="Sec36">
<title>Conclusion</title>
<p>As illustrated in this review, the cerebellum is involved in a broad range of pathologies seen in the newborn period. In many cases, characterization of cerebellar involvement can facilitate diagnosis, guide management, and improve the ability to provide an accurate prognosis for the infant. While the cerebellum is a relatively small structure anatomically, it plays a critical role in overall neurodevelopment.</p>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare that they have no competing interests.</p>
</fn>
<fn>
<p>
<bold>Authors’ contributions</bold>
</p>
<p>JLK, MEL and AP conceptualized and drafted this review article; All the co-authors critically revised the manuscript for intellectual content and read and approved the final manuscript.</p>
</fn>
</fn-group>
<ack>
<sec id="FPar1">
<title>Grant/financial support</title>
<p>FJN is supported by NIH-HD070996.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glass</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Bonifacio</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Peloquin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shimotake</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sehring</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurocritical care for neonates</article-title>
<source/>Neurocrit Care
          <year>2010</year>
<volume>12</volume>
<issue>3</issue>
<fpage>421</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1007/s12028-009-9324-7</pub-id>
<pub-id pub-id-type="pmid">20066514</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krienen</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Buckner</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Segregated fronto-cerebellar circuits revealed by intrinsic functional connectivity</article-title>
<source/>Cereb Cortex
          <year>2009</year>
<volume>19</volume>
<issue>10</issue>
<fpage>2485</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhp135</pub-id>
<pub-id pub-id-type="pmid">19592571</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stoodley</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>The cerebellum and cognition: evidence from functional imaging studies</article-title>
<source/>Cerebellum
          <year>2012</year>
<volume>11</volume>
<issue>2</issue>
<fpage>352</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1007/s12311-011-0260-7</pub-id>
<pub-id pub-id-type="pmid">21373864</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmahmann</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>The cerebellar cognitive affective syndrome</article-title>
<source/>Brain
          <year>1998</year>
<volume>121</volume>
<issue>Pt 4</issue>
<fpage>561</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1093/brain/121.4.561</pub-id>
<pub-id pub-id-type="pmid">9577385</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexiou</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Sfakianos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Prodromou</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Dandy-Walker malformation: analysis of 19 cases</article-title>
<source/>J Child Neurol
          <year>2010</year>
<volume>25</volume>
<issue>2</issue>
<fpage>188</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1177/0883073809338410</pub-id>
<pub-id pub-id-type="pmid">19833975</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bosemani</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Orman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Boltshauser</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tekes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Huisman</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Poretti</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Congenital abnormalities of the posterior fossa</article-title>
<source/>Radiographics
          <year>2015</year>
<volume>35</volume>
<issue>1</issue>
<fpage>200</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1148/rg.351140038</pub-id>
<pub-id pub-id-type="pmid">25590398</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boddaert</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sonigo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Parisot</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hertz-Pannier</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intellectual prognosis of the Dandy-Walker malformation in children: the importance of vermian lobulation</article-title>
<source/>Neuroradiology
          <year>2003</year>
<volume>45</volume>
<issue>5</issue>
<fpage>320</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">12682795</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Micalizzi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Valente</surname>
<given-names>EM</given-names>
</name>
</person-group>
<article-title>Joubert syndrome: congenital cerebellar ataxia with the molar tooth</article-title>
<source/>Lancet Neurol
          <year>2013</year>
<volume>12</volume>
<issue>9</issue>
<fpage>894</fpage>
<lpage>905</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(13)70136-4</pub-id>
<pub-id pub-id-type="pmid">23870701</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bachmann-Gagescu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dempsey</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Phelps</surname>
<given-names>IG</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Knutzen</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Rue</surname>
<given-names>TC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Joubert syndrome: a model for untangling recessive disorders with extreme genetic heterogeneity</article-title>
<source/>J Med Genet
          <year>2015</year>
<volume>52</volume>
<issue>8</issue>
<fpage>514</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103087</pub-id>
<pub-id pub-id-type="pmid">26092869</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maria</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Boltshauser</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>TX</given-names>
</name>
</person-group>
<article-title>Clinical features and revised diagnostic criteria in Joubert syndrome</article-title>
<source/>J Child Neurol
          <year>1999</year>
<volume>14</volume>
<issue>9</issue>
<fpage>583</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1177/088307389901400906</pub-id>
<pub-id pub-id-type="pmid">10488903</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poretti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Christen</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Elton</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Baumgartner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Korenke</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Sukhudyan</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Horizontal head titubation in infants with Joubert syndrome: a new finding</article-title>
<source/>Dev Med Child Neurol
          <year>2014</year>
<volume>56</volume>
<issue>10</issue>
<fpage>1016</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1111/dmcn.12489</pub-id>
<pub-id pub-id-type="pmid">24814865</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poretti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Huisman</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Scheer</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Boltshauser</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Joubert syndrome and related disorders: spectrum of neuroimaging findings in 75 patients</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2011</year>
<volume>32</volume>
<issue>8</issue>
<fpage>1459</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.3174/ajnr.A2517</pub-id>
<pub-id pub-id-type="pmid">21680654</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poretti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alber</surname>
<given-names>FD</given-names>
</name>
<name>
<surname>Burki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Toelle</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Boltshauser</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Cognitive outcome in children with rhombencephalosynapsis</article-title>
<source/>Eur J Paediatr Neurol
          <year>2009</year>
<volume>13</volume>
<issue>1</issue>
<fpage>28</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejpn.2008.02.005</pub-id>
<pub-id pub-id-type="pmid">18407532</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sukhudyan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jaladyan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Melikyan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schlump</surname>
<given-names>JU</given-names>
</name>
<name>
<surname>Boltshauser</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Poretti</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Gomez-Lopez-Hernandez syndrome: reappraisal of the diagnostic criteria</article-title>
<source/>Eur J Pediatr
          <year>2010</year>
<volume>169</volume>
<issue>12</issue>
<fpage>1523</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1007/s00431-010-1259-7</pub-id>
<pub-id pub-id-type="pmid">20652311</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishak</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Dempsey</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Tully</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Sanchez-Lara</surname>
<given-names>PA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rhombencephalosynapsis: a hindbrain malformation associated with incomplete separation of midbrain and forebrain, hydrocephalus and a broad spectrum of severity</article-title>
<source/>Brain
          <year>2012</year>
<volume>135</volume>
<issue>Pt 5</issue>
<fpage>1370</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1093/brain/aws065</pub-id>
<pub-id pub-id-type="pmid">22451504</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Namavar</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Barth</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Poll-The</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Baas</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia</article-title>
<source/>Orphanet J Rare Dis
          <year>2011</year>
<volume>6</volume>
<fpage>50</fpage>
<pub-id pub-id-type="doi">10.1186/1750-1172-6-50</pub-id>
<pub-id pub-id-type="pmid">21749694</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barth</surname>
<given-names>PG</given-names>
</name>
</person-group>
<article-title>Pontocerebellar hypoplasias. An overview of a group of inherited neurodegenerative disorders with fetal onset</article-title>
<source/>Brain Dev
          <year>1993</year>
<volume>15</volume>
<issue>6</issue>
<fpage>411</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1016/0387-7604(93)90080-R</pub-id>
<pub-id pub-id-type="pmid">8147499</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albrecht</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Belmont</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Fatal infantile encephalopathy with olivopontocerebellar hypoplasia and micrencephaly. Report of three siblings</article-title>
<source/>Acta Neuropathol
          <year>1993</year>
<volume>85</volume>
<issue>4</issue>
<fpage>394</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1007/BF00334450</pub-id>
<pub-id pub-id-type="pmid">8480512</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edvardson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shaag</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kolesnikova</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Gomori</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Tarassov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Einbinder</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia</article-title>
<source/>Am J Hum Genet
          <year>2007</year>
<volume>81</volume>
<issue>4</issue>
<fpage>857</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1086/521227</pub-id>
<pub-id pub-id-type="pmid">17847012</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Namavar</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Barth</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Kasher</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>van Ruissen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Brockmann</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bernert</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia</article-title>
<source/>Brain
          <year>2011</year>
<volume>134</volume>
<issue>Pt 1</issue>
<fpage>143</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awq287</pub-id>
<pub-id pub-id-type="pmid">20952379</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonnemann</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Quijano-Roy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Deconinck</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bertini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ferreiro</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic approach to the congenital muscular dystrophies</article-title>
<source/>Neuromuscul Disord
          <year>2014</year>
<volume>24</volume>
<issue>4</issue>
<fpage>289</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="doi">10.1016/j.nmd.2013.12.011</pub-id>
<pub-id pub-id-type="pmid">24581957</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clement</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mercuri</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Godfrey</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Robb</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kinali</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain involvement in muscular dystrophies with defective dystroglycan glycosylation</article-title>
<source/>Ann Neurol
          <year>2008</year>
<volume>64</volume>
<issue>5</issue>
<fpage>573</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1002/ana.21482</pub-id>
<pub-id pub-id-type="pmid">19067344</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godfrey</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Clement</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mein</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brockington</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Talim</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan</article-title>
<source/>Brain
          <year>2007</year>
<volume>130</volume>
<issue>Pt 10</issue>
<fpage>2725</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awm212</pub-id>
<pub-id pub-id-type="pmid">17878207</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boltshauser</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Scheer</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Huisman</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Poretti</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Cerebellar cysts in children: a pattern recognition approach</article-title>
<source/>Cerebellum
          <year>2015</year>
<volume>14</volume>
<issue>3</issue>
<fpage>308</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1007/s12311-014-0633-9</pub-id>
<pub-id pub-id-type="pmid">25504001</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barth</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Majoie</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Caan</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Weterman</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Kyllerman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Smit</surname>
<given-names>LM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pontine tegmental cap dysplasia: a novel brain malformation with a defect in axonal guidance</article-title>
<source/>Brain
          <year>2007</year>
<volume>130</volume>
<issue>Pt 9</issue>
<fpage>2258</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awm188</pub-id>
<pub-id pub-id-type="pmid">17690130</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rauscher</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Poretti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Neuhann</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Forstner</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pontine tegmental cap dysplasia: the severe end of the clinical spectrum</article-title>
<source/>Neuropediatrics
          <year>2009</year>
<volume>40</volume>
<issue>1</issue>
<fpage>43</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1055/s-0029-1224100</pub-id>
<pub-id pub-id-type="pmid">19639528</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poretti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Denecke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Schiffmann</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Buhk</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Grange</surname>
<given-names>DK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brainstem disconnection: two additional patients and expansion of the phenotype</article-title>
<source/>Neuropediatrics
          <year>2015</year>
<volume>46</volume>
<issue>2</issue>
<fpage>139</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1055/s-0034-1544127</pub-id>
<pub-id pub-id-type="pmid">25671339</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLone</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>The Chiari II malformation: cause and impact</article-title>
<source/>Childs Nerv Syst
          <year>2003</year>
<volume>19</volume>
<issue>7–8</issue>
<fpage>540</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1007/s00381-003-0792-3</pub-id>
<pub-id pub-id-type="pmid">12920543</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ocal</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Irwin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cochrane</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Singhal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Steinbok</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Stridor at birth predicts poor outcome in neonates with myelomeningocele</article-title>
<source/>Childs Nerv Syst
          <year>2012</year>
<volume>28</volume>
<issue>2</issue>
<fpage>265</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1007/s00381-011-1585-8</pub-id>
<pub-id pub-id-type="pmid">21947019</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Widjaja</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Blaser</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dennis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Raybaud</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The old and the new: supratentorial MR findings in Chiari II malformation</article-title>
<source/>Childs Nerv Syst
          <year>2008</year>
<volume>24</volume>
<issue>5</issue>
<fpage>563</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1007/s00381-007-0528-x</pub-id>
<pub-id pub-id-type="pmid">18026960</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adzick</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Thom</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Spong</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Brock</surname>
<given-names>JW</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Burrows</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>MP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A randomized trial of prenatal versus postnatal repair of myelomeningocele</article-title>
<source/>N Engl J Med
          <year>2011</year>
<volume>364</volume>
<issue>11</issue>
<fpage>993</fpage>
<lpage>1004</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1014379</pub-id>
<pub-id pub-id-type="pmid">21306277</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verbeek</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Heep</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Maurits</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Cremer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hoving</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Brouwer</surname>
<given-names>OF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fetal endoscopic myelomeningocele closure preserves segmental neurological function</article-title>
<source/>Dev Med Child Neurol
          <year>2012</year>
<volume>54</volume>
<issue>1</issue>
<fpage>15</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.2011.04148.x</pub-id>
<pub-id pub-id-type="pmid">22126123</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freeze</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>JX</given-names>
</name>
<name>
<surname>Bamshad</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>BG</given-names>
</name>
</person-group>
<article-title>Solving glycosylation disorders: fundamental approaches reveal complicated pathways</article-title>
<source/>Am J Hum Genet
          <year>2014</year>
<volume>94</volume>
<issue>2</issue>
<fpage>161</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2013.10.024</pub-id>
<pub-id pub-id-type="pmid">24507773</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feraco</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mirabelli-Badenier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Severino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alpigiani</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Di Rocco</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Biancheri</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The shrunken, bright cerebellum: a characteristic MRI finding in congenital disorders of glycosylation type 1a</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2012</year>
<volume>33</volume>
<issue>11</issue>
<fpage>2062</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.3174/ajnr.A3151</pub-id>
<pub-id pub-id-type="pmid">22723063</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelley</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Hennekam</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>The Smith-Lemli-Opitz syndrome</article-title>
<source/>J Med Genet
          <year>2000</year>
<volume>37</volume>
<issue>5</issue>
<fpage>321</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.37.5.321</pub-id>
<pub-id pub-id-type="pmid">10807690</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poretti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Blaser</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Lequin</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Fatemi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meoded</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Northington</surname>
<given-names>FJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neonatal neuroimaging findings in inborn errors of metabolism</article-title>
<source/>J Magn Reson Imaging
          <year>2013</year>
<volume>37</volume>
<issue>2</issue>
<fpage>294</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="doi">10.1002/jmri.23693</pub-id>
<pub-id pub-id-type="pmid">22566357</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoover-Fong</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Van Hove</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Applegarth</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Toone</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hamosh</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Natural history of nonketotic hyperglycinemia in 65 patients</article-title>
<source/>Neurology
          <year>2004</year>
<volume>63</volume>
<issue>10</issue>
<fpage>1847</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1212/01.WNL.0000144270.83080.29</pub-id>
<pub-id pub-id-type="pmid">15557500</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morton</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Strauss</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Puffenberger</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>RI</given-names>
</name>
</person-group>
<article-title>Diagnosis and treatment of maple syrup disease: a study of 36 patients</article-title>
<source/>Pediatrics
          <year>2002</year>
<volume>109</volume>
<issue>6</issue>
<fpage>999</fpage>
<lpage>1008</lpage>
<pub-id pub-id-type="doi">10.1542/peds.109.6.999</pub-id>
<pub-id pub-id-type="pmid">12042535</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riviello</surname>
<given-names>JJ</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Rezvani</surname>
<given-names>I</given-names>
</name>
<name>
<surname>DiGeorge</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Foley</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Cerebral edema causing death in children with maple syrup urine disease</article-title>
<source/>J Pediatr
          <year>1991</year>
<volume>119</volume>
<issue>1 Pt 1</issue>
<fpage>42</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(05)81036-4</pub-id>
<pub-id pub-id-type="pmid">2066857</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simon</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fingerhut</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Baumkotter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Konstantopoulou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ratschmann</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wendel</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease</article-title>
<source/>J Inherit Metab Dis
          <year>2006</year>
<volume>29</volume>
<issue>4</issue>
<fpage>532</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-006-0315-y</pub-id>
<pub-id pub-id-type="pmid">16817013</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnerias</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Saudubray</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Touati</surname>
<given-names>G</given-names>
</name>
<name>
<surname>De Lonlay</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dulac</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ponsot</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis</article-title>
<source/>Dev Med Child Neurol
          <year>2010</year>
<volume>52</volume>
<issue>2</issue>
<fpage>e1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.2009.03541.x</pub-id>
<pub-id pub-id-type="pmid">20002125</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayram</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Topcu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Karakaya</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yis</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Cakmakci</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ichida</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molybdenum cofactor deficiency: review of 12 cases (MoCD and review)</article-title>
<source/>Eur J Paediatr Neurol
          <year>2013</year>
<volume>17</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejpn.2012.10.003</pub-id>
<pub-id pub-id-type="pmid">23122324</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bindu</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Christopher</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mahadevan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bharath</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Clinical and imaging observations in isolated sulfite oxidase deficiency</article-title>
<source/>J Child Neurol
          <year>2011</year>
<volume>26</volume>
<issue>8</issue>
<fpage>1036</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1177/0883073811401399</pub-id>
<pub-id pub-id-type="pmid">21572056</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hobson</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Crofton</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Isolated sulphite oxidase deficiency mimics the features of hypoxic ischaemic encephalopathy</article-title>
<source/>Eur J Pediatr
          <year>2005</year>
<volume>164</volume>
<issue>11</issue>
<fpage>655</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1007/s00431-005-1729-5</pub-id>
<pub-id pub-id-type="pmid">16025295</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hitzert</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Bos</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Bergman</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Veldman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Santamaria-Araujo</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Favorable outcome in a newborn with molybdenum cofactor type A deficiency treated with cPMP</article-title>
<source/>Pediatrics
          <year>2012</year>
<volume>130</volume>
<issue>4</issue>
<fpage>e1005</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2011-3330</pub-id>
<pub-id pub-id-type="pmid">22987873</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakai</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment</article-title>
<source/>Brain Dev
          <year>2009</year>
<volume>31</volume>
<issue>7</issue>
<fpage>485</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.braindev.2009.03.001</pub-id>
<pub-id pub-id-type="pmid">19332366</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahai</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Baris</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kimonis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>HL</given-names>
</name>
</person-group>
<article-title>Krabbe disease: severe neonatal presentation with a family history of multiple sclerosis</article-title>
<source/>J Child Neurol
          <year>2005</year>
<volume>20</volume>
<issue>10</issue>
<fpage>826</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1177/08830738050200100901</pub-id>
<pub-id pub-id-type="pmid">16417879</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falik-Zaccai</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Laskar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kfir</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nasser</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Slor</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Khayat</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Cockayne syndrome type II in a Druze isolate in Northern Israel in association with an insertion mutation in ERCC6</article-title>
<source/>Am J Med Genet A
          <year>2008</year>
<volume>146A</volume>
<issue>11</issue>
<fpage>1423</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.32309</pub-id>
<pub-id pub-id-type="pmid">18446857</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hobson</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Garbern</surname>
<given-names>JY</given-names>
</name>
</person-group>
<article-title>Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders</article-title>
<source/>Semin Neurol
          <year>2012</year>
<volume>32</volume>
<issue>1</issue>
<fpage>62</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1055/s-0032-1306388</pub-id>
<pub-id pub-id-type="pmid">22422208</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uggetti</surname>
<given-names>C</given-names>
</name>
<name>
<surname>La Piana</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Orcesi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Egitto</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Crow</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Fazzi</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Aicardi-Goutieres syndrome: neuroradiologic findings and follow-up</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2009</year>
<volume>30</volume>
<issue>10</issue>
<fpage>1971</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.3174/ajnr.A1694</pub-id>
<pub-id pub-id-type="pmid">19628626</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siintola</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Partanen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stromme</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Haapanen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Haltia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Maehlen</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis</article-title>
<source/>Brain
          <year>2006</year>
<volume>129</volume>
<issue>Pt 6</issue>
<fpage>1438</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awl107</pub-id>
<pub-id pub-id-type="pmid">16670177</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matilla-Duenas</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The ever expanding spinocerebellar ataxias</article-title>
<source/>Editorial Cerebellum
          <year>2012</year>
<volume>11</volume>
<issue>4</issue>
<fpage>821</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1007/s12311-012-0376-4</pub-id>
<pub-id pub-id-type="pmid">22447528</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrison</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Paediatric and adult autosomal dominant ataxias (update 6)</article-title>
<source/>Eur J Paediatr Neurol
          <year>2010</year>
<volume>14</volume>
<issue>3</issue>
<fpage>261</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejpn.2009.07.003</pub-id>
<pub-id pub-id-type="pmid">19665402</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paciorkowski</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Shafrir</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hrivnak</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Tennison</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>HB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms</article-title>
<source/>Neurology
          <year>2011</year>
<volume>77</volume>
<issue>11</issue>
<fpage>1055</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e31822e5627</pub-id>
<pub-id pub-id-type="pmid">21880993</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babovic-Vuksanovic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Snow</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Michels</surname>
<given-names>VV</given-names>
</name>
</person-group>
<article-title>Spinocerebellar ataxia type 2 (SCA 2) in an infant with extreme CAG repeat expansion</article-title>
<source/>Am J Med Genet
          <year>1998</year>
<volume>79</volume>
<issue>5</issue>
<fpage>383</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19981012)79:5&lt;383::AID-AJMG10&gt;3.0.CO;2-N</pub-id>
<pub-id pub-id-type="pmid">9779806</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Aylsworth</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Breningstall</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wick</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7</article-title>
<source/>Am J Med Genet
          <year>2002</year>
<volume>110</volume>
<issue>4</issue>
<fpage>338</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.10467</pub-id>
<pub-id pub-id-type="pmid">12116207</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benton</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>de Silva</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rutledge</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Bohlega</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ashizawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype</article-title>
<source/>Neurology
          <year>1998</year>
<volume>51</volume>
<issue>4</issue>
<fpage>1081</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.51.4.1081</pub-id>
<pub-id pub-id-type="pmid">9781533</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van de Warrenburg</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Frenken</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Ausems</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sinke</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Knoers</surname>
<given-names>NV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Striking anticipation in spinocerebellar ataxia type 7: the infantile phenotype</article-title>
<source/>J Neurol
          <year>2001</year>
<volume>248</volume>
<issue>10</issue>
<fpage>911</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1007/s004150170082</pub-id>
<pub-id pub-id-type="pmid">11697534</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volpe</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Cerebellum of the premature infant: rapidly developing, vulnerable, clinically important</article-title>
<source/>J Child Neurol
          <year>2009</year>
<volume>24</volume>
<issue>9</issue>
<fpage>1085</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1177/0883073809338067</pub-id>
<pub-id pub-id-type="pmid">19745085</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messerschmidt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brugger</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Boltshauser</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zoder</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sterniste</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Birnbacher</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of cerebellar development: potential complication of extreme prematurity</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2005</year>
<volume>26</volume>
<issue>7</issue>
<fpage>1659</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="pmid">16091510</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limperopoulos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chilingaryan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Guizard</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>du Plessis</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Injury to the premature cerebellum: outcome is related to remote cortical development</article-title>
<source/>Cereb Cortex
          <year>2014</year>
<volume>24</volume>
<issue>3</issue>
<fpage>728</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhs354</pub-id>
<pub-id pub-id-type="pmid">23146968</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limperopoulos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Soul</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Haidar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Huppi</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Bassan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Warfield</surname>
<given-names>SK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired trophic interactions between the cerebellum and the cerebrum among preterm infants</article-title>
<source/>Pediatrics
          <year>2005</year>
<volume>116</volume>
<issue>4</issue>
<fpage>844</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2004-2282</pub-id>
<pub-id pub-id-type="pmid">16199692</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messerschmidt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fuiko</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Prayer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Brugger</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Boltshauser</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zoder</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disrupted cerebellar development in preterm infants is associated with impaired neurodevelopmental outcome</article-title>
<source/>Eur J Pediatr
          <year>2008</year>
<volume>167</volume>
<issue>10</issue>
<fpage>1141</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1007/s00431-007-0647-0</pub-id>
<pub-id pub-id-type="pmid">18172680</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brossard-Racine</surname>
<given-names>M</given-names>
</name>
<name>
<surname>du Plessis</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Limperopoulos</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Developmental cerebellar cognitive affective syndrome in ex-preterm survivors following cerebellar injury</article-title>
<source/>Cerebellum
          <year>2015</year>
<volume>14</volume>
<issue>2</issue>
<fpage>151</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1007/s12311-014-0597-9</pub-id>
<pub-id pub-id-type="pmid">25241880</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limperopoulos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Bassan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Disalvo</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Kinnamon</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cerebellar hemorrhage in the preterm infant: ultrasonographic findings and risk factors</article-title>
<source/>Pediatrics
          <year>2005</year>
<volume>116</volume>
<issue>3</issue>
<fpage>717</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2005-0556</pub-id>
<pub-id pub-id-type="pmid">16140713</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merrill</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Piecuch</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Fell</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Barkovich</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>RB</given-names>
</name>
</person-group>
<article-title>A new pattern of cerebellar hemorrhages in preterm infants</article-title>
<source/>Pediatrics
          <year>1998</year>
<volume>102</volume>
<issue>6</issue>
<fpage>E62</fpage>
<pub-id pub-id-type="doi">10.1542/peds.102.6.e62</pub-id>
<pub-id pub-id-type="pmid">9832590</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steggerda</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>De Bruine</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>van den Berg-Huysmans</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Rijken</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leijser</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Walther</surname>
<given-names>FJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Small cerebellar hemorrhage in preterm infants: perinatal and postnatal factors and outcome</article-title>
<source/>Cerebellum
          <year>2013</year>
<volume>12</volume>
<issue>6</issue>
<fpage>794</fpage>
<lpage>801</lpage>
<pub-id pub-id-type="doi">10.1007/s12311-013-0487-6</pub-id>
<pub-id pub-id-type="pmid">23653170</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limperopoulos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Bassan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>du Plessis</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Cerebellar injury in term infants: clinical characteristics, magnetic resonance imaging findings, and outcome</article-title>
<source/>Pediatr Neurol
          <year>2009</year>
<volume>41</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2009.02.007</pub-id>
<pub-id pub-id-type="pmid">19520266</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tam</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Rosenbluth</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Ferriero</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Glidden</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>RB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cerebellar hemorrhage on magnetic resonance imaging in preterm newborns associated with abnormal neurologic outcome</article-title>
<source/>J Pediatr
          <year>2011</year>
<volume>158</volume>
<issue>2</issue>
<fpage>245</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2010.07.049</pub-id>
<pub-id pub-id-type="pmid">20833401</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limperopoulos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bassan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gauvreau</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>RL</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Sullivan</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>CB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Does cerebellar injury in premature infants contribute to the high prevalence of long-term cognitive, learning, and behavioral disability in survivors?</article-title>
<source/>Pediatrics
          <year>2007</year>
<volume>120</volume>
<issue>3</issue>
<fpage>584</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2007-1041</pub-id>
<pub-id pub-id-type="pmid">17766532</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kersbergen</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Groenendaal</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Benders</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>LS</given-names>
</name>
</person-group>
<article-title>Neonatal cerebral sinovenous thrombosis: neuroimaging and long-term follow-up</article-title>
<source/>J Child Neurol
          <year>2011</year>
<volume>26</volume>
<issue>9</issue>
<fpage>1111</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1177/0883073811408090</pub-id>
<pub-id pub-id-type="pmid">21693652</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>deVeber</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Andrew</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bjornson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Booth</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>DJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cerebral sinovenous thrombosis in children</article-title>
<source/>N Engl J Med
          <year>2001</year>
<volume>345</volume>
<issue>6</issue>
<fpage>417</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM200108093450604</pub-id>
<pub-id pub-id-type="pmid">11496852</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berfelo</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Kersbergen</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>van Ommen</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Govaert</surname>
<given-names>P</given-names>
</name>
<name>
<surname>van Straaten</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Poll-The</surname>
<given-names>BT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neonatal cerebral sinovenous thrombosis from symptom to outcome</article-title>
<source/>Stroke
          <year>2010</year>
<volume>41</volume>
<issue>7</issue>
<fpage>1382</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.110.583542</pub-id>
<pub-id pub-id-type="pmid">20522810</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moharir</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Shroff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pontigon</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Askalan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yau</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Macgregor</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A prospective outcome study of neonatal cerebral sinovenous thrombosis</article-title>
<source/>J Child Neurol
          <year>2011</year>
<volume>26</volume>
<issue>9</issue>
<fpage>1137</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1177/0883073811408094</pub-id>
<pub-id pub-id-type="pmid">21628696</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnsen</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Tarby</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Prenger</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Cerebellar infarction: an unrecognized complication of very low birthweight</article-title>
<source/>J Child Neurol
          <year>2002</year>
<volume>17</volume>
<issue>5</issue>
<fpage>320</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1177/088307380201700502</pub-id>
<pub-id pub-id-type="pmid">12150576</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golomb</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Edwards-Brown</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>LS</given-names>
</name>
</person-group>
<article-title>Very early arterial ischemic stroke in premature infants</article-title>
<source/>Pediatr Neurol
          <year>2008</year>
<volume>38</volume>
<issue>5</issue>
<fpage>329</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2007.12.012</pub-id>
<pub-id pub-id-type="pmid">18410848</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volpe</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Neonatal encephalopathy: an inadequate term for hypoxic-ischemic encephalopathy</article-title>
<source/>Ann Neurol
          <year>2012</year>
<volume>72</volume>
<issue>2</issue>
<fpage>156</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1002/ana.23647</pub-id>
<pub-id pub-id-type="pmid">22926849</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zwiener</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kratzsch</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Marked reduction of brainstem blood flow in artificially ventilated newborn piglets during normoxia and normocapnic hypoxia</article-title>
<source/>Intensive Care Med
          <year>2003</year>
<volume>29</volume>
<issue>12</issue>
<fpage>2277</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1007/s00134-003-2007-5</pub-id>
<pub-id pub-id-type="pmid">14564376</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castillo</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Selective vulnerability and the cerebellum in neonates</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2007</year>
<volume>28</volume>
<issue>1</issue>
<fpage>20</fpage>
<lpage>1</lpage>
<pub-id pub-id-type="pmid">17213416</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boudes</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Saint-Martin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shevell</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Injury to the cerebellum in term asphyxiated newborns treated with hypothermia</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2015</year>
<volume>36</volume>
<issue>8</issue>
<fpage>1542</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.3174/ajnr.A4326</pub-id>
<pub-id pub-id-type="pmid">26138137</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sargent</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Poskitt</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Roland</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hendson</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Cerebellar vermian atrophy after neonatal hypoxic-ischemic encephalopathy</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2004</year>
<volume>25</volume>
<issue>6</issue>
<fpage>1008</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">15205139</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Connolly</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Widjaja</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Griffiths</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>Involvement of the anterior lobe of the cerebellar vermis in perinatal profound hypoxia</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2007</year>
<volume>28</volume>
<issue>1</issue>
<fpage>16</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">17213415</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Strange</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Saeed</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cowan</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Rutherford</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>MR imaging quantification of cerebellar growth following hypoxic-ischemic injury to the neonatal brain</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2004</year>
<volume>25</volume>
<issue>3</issue>
<fpage>463</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">15037473</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Vries</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Gunardi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Barth</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Bok</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Verboon-Maciolek</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Groenendaal</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The spectrum of cranial ultrasound and magnetic resonance imaging abnormalities in congenital cytomegalovirus infection</article-title>
<source/>Neuropediatrics
          <year>2004</year>
<volume>35</volume>
<issue>2</issue>
<fpage>113</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1055/s-2004-815833</pub-id>
<pub-id pub-id-type="pmid">15127310</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oosterom</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nijman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gunkel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wolfs</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Groenendaal</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Verboon-Maciolek</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuro-imaging findings in infants with congenital cytomegalovirus infection: relation to trimester of infection</article-title>
<source/>Neonatology
          <year>2015</year>
<volume>107</volume>
<issue>4</issue>
<fpage>289</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1159/000375439</pub-id>
<pub-id pub-id-type="pmid">25790782</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vossough</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Bilaniuk</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>EM</given-names>
</name>
</person-group>
<article-title>Imaging findings of neonatal herpes simplex virus type 2 encephalitis</article-title>
<source/>Neuroradiology
          <year>2008</year>
<volume>50</volume>
<issue>4</issue>
<fpage>355</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1007/s00234-007-0349-3</pub-id>
<pub-id pub-id-type="pmid">18246335</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pavlik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Buresova</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The neonatal cerebellum: the highest level of glucocorticoid receptors in the brain</article-title>
<source/>Brain Res
          <year>1984</year>
<volume>314</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1016/0165-3806(84)90171-8</pub-id>
<pub-id pub-id-type="pmid">6697248</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noguchi</surname>
<given-names>KK</given-names>
</name>
</person-group>
<article-title>Glucocorticoid induced cerebellar toxicity in the developing neonate: implications for glucocorticoid therapy during bronchopulmonary dysplasia</article-title>
<source/>Cells
          <year>2014</year>
<volume>3</volume>
<issue>1</issue>
<fpage>36</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.3390/cells3010036</pub-id>
<pub-id pub-id-type="pmid">24501683</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parikh</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Lasky</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Moya</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Hochhauser</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Romo</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infants</article-title>
<source/>Pediatrics
          <year>2007</year>
<volume>119</volume>
<issue>2</issue>
<fpage>265</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2006-1354</pub-id>
<pub-id pub-id-type="pmid">17272615</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tam</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Chau</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ferriero</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Barkovich</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Poskitt</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Studholme</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Preterm cerebellar growth impairment after postnatal exposure to glucocorticoids</article-title>
<source/>Sci Transl Med
          <year>2011</year>
<volume>3</volume>
<issue>105</issue>
<fpage>105ra</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3002884</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavalheiro</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moron</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Hisaba</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Dastoli</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>NS</given-names>
</name>
</person-group>
<article-title>Fetal brain tumors</article-title>
<source/>Childs Nerv Syst
          <year>2003</year>
<volume>19</volume>
<issue>7–8</issue>
<fpage>529</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1007/s00381-003-0770-9</pub-id>
<pub-id pub-id-type="pmid">12908112</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>